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GUEST EDITORIAL
Contributor: Jan Slingenbergh1 
This edition of empres360 reports on African human and animal trypanosomoses. In many ways, the Programme Against African Trypanosomosis (PAAT) represents a 
forerunner of the One Health initiative. PAAT works across 
sectors, disciplines, scales and geographic boundaries, while 
focusing on a composite of sustainable development goals. It is 
somewhat unusual for an animal health bulletin that concentrates on 
“emergencies”  to pay attention to parasitic or protozoan diseases. 
After all, infectious diseases are the ones that cause major disease 
outbreaks and call for immediate attention, while parasites are 
more likely to be responsible for endemic disease burdens. This 
situation calls for reflection on the setting of priorities in disease 
management, within the Food and Agriculture Organization of the 
United Nations (FAO) and beyond. FAO always seeks to balance 
emergency response and the need for long-term development 
efforts. The FAO animal disease portfolio has always featured a mix 
of infectious disease initiatives, such as those against rinderpest, 
peste des petits ruminants or foot-and-mouth disease (FMD), along 
with programmes against African animal trypanosomosis and other 
parasitic diseases.
In retrospect, the fight against classical infectious livestock 
diseases has been relatively successful for some time, arguably 
more so than the efforts against parasitic diseases. A parallel 
development occurred in the fight against human diseases: the 
availability of vaccines against well-researched viral and bacterial 
diseases probably formed a main factor in this success. Rinderpest, 
contagious bovine pleuropneumonia, FMD, sheep and goat pox, 
bovine brucellosis, glanders, Newcastle disease, classical swine 
fever, anthrax and blackleg are among the classical livestock diseases 
that have started to disappear from a growing number of countries 
around the world. Gradually, new tools for combating macro-
parasites and arthropod vectors have became available, in both the 
veterinary and human medical fields. The control of river blindness in 
West Africa, the Roll Back Malaria partnership, and the new world 
screwworm emergency campaign in North Africa are among the 
noteworthy late-twentieth-century achievements in both sectors.
However, towards the end of the twentieth century, a counter-
force to these achievements became more prominent, changing 
the global disease landscape forever. A growing number of 
animal-origin viruses started to infect and spread in humans as 
viruses were exchanged among the wildlife, livestock and human 
host domains. With a wildlife sector of more than 5 600 mammal 
species, 17 or so livestock species and only one human species, 
the predominant direction of this interdomain virus flow is obvious. 
Non-human primates, bats, rodents and birds form reservoirs of 
1 Former Head of EMPRES Animal Health
viruses that cause only inapparent infection in their primary hosts. 
Humans become infected and clinically ill after direct contact with 
infected animals, through bushmeat-related practices, bloodsucking 
arthropods or food and agriculture. The drivers of global disease 
dynamics are believed to comprise human demographics, 
pressures on land and water resources, increased mobility, trade 
and transport volumes, climate change, deforestation and general 
degradation of natural ecosystems. 
Agricultural expansion is a main cause of ecosystem damage, 
particularly in places where forest is replaced by rainfed crops. 
The replacement of forest by cropland peaked during the 1990s 
in Latin America and around 2010 in Asia; in Africa it is projected 
to peak around 2020 but to remain important until at least 2050. 
In Asia, livestock or farmed wildlife were involved in most recent 
virus spillovers from animals to humans: severe acute respiratory 
syndrome, Nipah, H5N1 avian influenza and other influenza A 
viruses. The spill-over of influenza is facilitated by the explosive 
increase in poultry and pig production in China and other Asian 
countries. An ever-more diverse pool of influenza A virus genes is 
building up and circulating in humans, swine and poultry. In Asia, 
food and agriculture systems play an important role in disease 
emergence, with zoonotic viruses circulating in livestock prior to the 
jump to humans. In Africa, in contrast, the human immunodeficiency, 
Ebola, dengue, yellow fever, chikungunya and Zika viruses have all 
come directly out of the forest to infect humans, so the transmission 
and disease ecology are accordingly different. 
The continuing emergence of animal-origin viruses in humans 
presents a global health and security risk. For FAO, reducing 
pandemic threats is a main target, and efforts are currently 
supported by the United States Agency for International 
Development. The priority is to build up core veterinary capabilities 
in the less developed countries where they are most needed, in 
terms of staff, laboratories and surveillance. In addition, sustained 
pandemic risk reduction in these settings requires that health 
protection, food security, natural resource management and 
opportunities for securing basic income are addressed together. 
Although international efforts are moving towards global early 
warning and response mechanisms, novel pandemic threats will 
continue to emerge unless the livelihoods of the people directly 
concerned are improved. In many countries the burden of persisting 
classical diseases is compounded by tropical, arthropod-borne and 
other infections, helminths and other parasites, which together are 
responsible for ill-health, hunger and poverty. Hence the need for 
all development and technical assistance agencies and actors to 
broaden the scope of their programmes. 360
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INTRODUCTION
Camelids play a crucial role in human communities located in dry, sometimes harsh and even hostile, environments 
such as deserts or high mountains (small 
camelids). They provide food (milk, meat), 
fibre (wool, leather) and draft power (for 
transportation and cultivation). Their capacity 
to travel long distances in water-scarce 
environments is another valuable asset for 
trade and communication throughout arid and 
semi-arid ecosystems.
Recently, camelid raising practices 
have been changing. On one hand, 
because of urbanization and motorization, 
traditional cultures that rely on camels and 
are associated with nomadic, sedentary 
or partially sedentary lifestyles are facing 
important changes with the decline of 
extensive husbandry. On the other hand, 
because the species can be raised in arid 
ecosystems and provides food products 
for millions of people, camel farming (dairy 
or meat) currently represents a sizeable 
and growing business, particularly under 
intensive production in peri-urban zones 
(Gossner et al., 2016). In the context of 
climate change, camels also represent a 
viable option for socio-ecosystems that are 
facing drier climate scenarios (Faye, Chaibou 
and Vias, 2012). 
Pathogens and diseases related to 
camelids are less well known than are 
those of other domesticated species, but 
have attracted growing attention recently. 
For instance, several unusual disease 
incidents caused by Trypanosoma evansi 
or morbillivirus infection, provoking high 
morbidity and/or mortality rates in dromedary 
camels (Camelus dromedarius), have been 
reported in the literature. There is increasing 
need to determine whether camels are 
clinically susceptible, as potential reservoirs 
and maintenance or bridge hosts, to viral 
pathogens affecting small ruminants, cattle 
and/or humans. Overall, dromedaries seem to 
be more resistant hosts for bovine, ovine or 
caprine viral diseases such as foot-and-mouth 
disease or rinderpest. 
The global population of large camelids 
is estimated to be about 28 million head 
(excluding Australian “wild” camels), of which 
95 percent are dromedary camels and the 
rest mainly Asian Bactrian camels (Camelus 
bactrianus) (Faye, 2015). The domesticated 
population of small camelids is about 8 million 
head. Sixty percent of the world’s camels are 
found in East African countries, which are 
important exporters of camels to the Arabian 
Peninsula and Egypt (Figure 1).
This paper focuses on three major viral 
infections of global concern and sanitary 
importance for human/animal health. It 
presents the various roles that camels could 
play in the epidemiology of these diseases, 
and identifies the research gaps for better 
understanding of the health risks represented 
by this species. 
CASE STUDY OF MIDDLE EAST 
RESPIRATORY SYNDROME 
CORONAVIRUS 
In September 2012, the first case of a human 
infected by a novel coronavirus, later named 
Middle East respiratory syndrome coronavirus 
(MERS-CoV), was identified in Saudi 
Arabia. By September 2016, 1 806 cases of 
MERS-CoV have been reported to the World 
Health Organization (WHO), with at least 
643 deaths (case fatality rate: 36 percent), 
mostly in Saudi Arabia but also touching 26 
other countries. MERS-CoV cases directly or 
indirectly associated with travel or residence in 
the Near East have been reported from many 
other countries around the world, but the first 
large outbreak outside the Arabian Peninsula 
was recently observed in the Republic of 
Korea and China, with 189 cases and 36 
deaths. It is important to note that the index 
case in this outbreak had recently travelled to 
the Near East. Although most documented 
human infections are nosocomial or, to a lesser 
extent, within households, dromedary camels 
are strongly suspected of acting as a zoonotic 
source for human cases, by either direct 
contact through droplet infection via mucous 
membranes or indirect contact through milk, 
meat or urine of dromedary camels. 
At least five arguments suggest that 
dromedary camels play an important role in 
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the epidemiology of MERS-CoV, possibly 
as a reservoir host. First, coronaviruses 
are widespread in the animal kingdom (in 
bats and livestock), but recent serological 
screenings indicate that MERS-CoV does not 
infect the majority of potential animal hosts 
(e.g. sheep, goats, cattle, chickens, water 
buffaloes, birds, horses and other camelids 
such as llamas, alpacas and Bactrian camels) 
(Reusken et al., 2013; Chan et al., 2015). 
However high levels of seroprevalence have 
been observed in dromedary camelids, 
ranging from 0 percent in Asia to as much 
as 100 percent in Africa and the Arabian 
Peninsula, where the mean is 79 percent 
(Figure 1). Second, the MERS-CoV viruses 
isolated from dromedaries are genetically 
and phenotypically very similar or identical to 
those infecting humans (Chan et al., 2014). 
Third, retrospective serological studies 
in Africa going back more than 30 years 
indicate long-term circulation of the virus 
in dromedary camels (Muller et al., 2014). 
Fourth, infection in dromedaries causes no 
or only mild respiratory symptoms, making it 
difficult to detect. Finally, Dudas and Rambaut 
(2015) showed that the MERS-CoV genome 
has likely undergone numerous recent 
recombinations, which suggests frequent 
co-infection, probably in camels, with distinct 
lineages of MERS-CoV. 
Although new research revealed traces of 
antibodies against MERS-CoV in handlers of 
indigenous livestock in Kenya in 2013/2014 
(Liljander et al., 2016), it is surprising that no 
locally acquired primary human cases have 
been reported where humans and dromedary 
camels are present outside the Arabian 
Peninsula. Recent workshops on MERS-
CoV (Doha in April 2015 and Cairo in May 
2015), organized by WHO, FAO and the 
World Organisation for Animal Health (OIE), 
have produced recommendations based on 
research. One of these recommendations 
is to investigate whether and why MERS-
CoV infections of humans do not occur in 
Africa despite the high levels of infection in 
dromedaries, and why the virus is apparently 
absent in camels in Central Asia (dromedary 
and Bactrian camels, Figure 1). The exact role 
of dromedary camels as a potential reservoir 
for MERS-CoV is also still unclear, and further 
investigations should be carried out to identify 
the mechanism of virus transmission more 
clearly. The role of bats – and maybe other 
micro-mammals such as rodents – should also 
be investigated. It is now crucial to understand 
the chain of transmission of the virus among 
wild/domestic animals and humans and the 
differences between transmission in Africa and 
the Arabian Peninsula (where MERS-CoV is 
now endemic).
CASE STUDY OF PESTE DES PETITS 
RUMINANTS 
Peste des petits ruminants (PPR) virus 
(PPRV) is a morbillivirus that affects small 
ruminants. Cattle are susceptible to infection 
but do not contract the disease or show 
overt clinical signs. PPR is not a zoonosis; 
the virus is significantly expanding in small 
ruminants in Africa, currently spreading 
from east and central towards southern 
Africa; the disease is also occurring in Asia, 
including China. Dromedary camels are 
known to be susceptible to PPRV (Roger 
et al., 2001), with an overall serological 
infection rate of 3.76 percent (n = 3 356) 
(Figure 1). Most of these studies were 
conducted on healthy animals. However, 
outbreaks of respiratory disease with 
observed mortality of about 7 percent are 
suspected to be linked to PPRV (Khalafalla 
et al., 2010). Mixed infections associated 
with PPRV could also trigger episodes of 
mortality – the PPRV immunosuppression 
effect could lead to secondary infections 
such as with Streptococcus equi subspecies 
equi (Yigezu et al., 1997) or bacteria from 
the Pasteurellaceae family. Respiratory 
syndromes with high morbidity and mortality 
rates, or mysterious mortalities (Dawo, 2014) 
occurring in camel populations necessitate 
better disease outbreak investigations.
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Figure 1: Geographical areas covered by major studies on viral camel infections
Details of all studies are provided in the list of references at the end of this paper. For reasons of space, only the first named author is cited in Figure 1. 
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CASE STUDY OF RIFT VALLEY FEVER 
Rift Valley fever (RVF), caused by a 
Phlebovirus (Bunyaviridae) and affecting 
both livestock and humans, is considered 
one of the most important arboviral zoonoses 
in Africa (Chevalier, 2013). The virus is 
transmitted: i) between ruminants, by 
mosquitoes and perhaps by direct contact 
with viraemic blood, abortion products or 
other excretions and secretions from viraemic 
animals; and ii) from ruminants to humans, 
mainly by direct contact but also by mosquito 
bites. Dromedary camels are susceptible 
to RVF virus (RVFV) and infections have 
been recorded in most sub-Saharan African 
countries, with serological prevalence rates 
ranging from 3.0 to 51.9 percent depending 
on sampling period and location (Figure 
1). Widespread abortion waves associated 
with positive serologic test results were 
observed in dromedary populations during 
RVF outbreaks in Kenya and Egypt. During 
the 2010 outbreak in Mauritania, two clinical 
forms were observed in dromedary camels: 
i) a peracute form with sudden death within 
24 hours; and ii) an acute form with fever, 
various systemic lesions and abortions. When 
haemorrhagic signs developed, death usually 
occurred within a few days (El Mamy et al., 
2011). However, mild forms and even a virus 
carrier state without clinical signs were also 
described. For instance, RVFV was isolated 
from blood samples from healthy, naturally 
infected dromedary camels in Egypt and the 
Sudan (Eisa, 1984; Imam, El-Karamany and 
Darwish, 1979) and experimental infections 
have induced no clinical signs in non-pregnant 
dromedaries.
Regarding transboundary spread, 
dromedaries may have brought the virus from 
north Sudan to south Egypt, where it caused 
the first Egyptian outbreak in 1977. Dromedary 
camels enter Egypt officially without any 
virological investigation and even without a 
sufficient period in quarantine facilities. A 
second study showed that RVFV was still 
circulating in dromedaries in Mauritania when 
the epidemic was officially declared over (El 
Mamy et al., 2011).
The potential role of dromedaries as 
amplifying hosts or virus spreaders therefore 
remains unclear. Dromedaries may act as 
amplifying hosts in some areas, but do not 
seem to be essential to the epidemiological 
cycle of RVF and its maintenance in all 
ecosystems. Viral circulation and/or large 
outbreaks have been reported in “camel-free” 
countries such as Madagascar or countries 
in Central and Southern Africa, although 
the presence of various cycles in specific 
socio-ecosystems cannot be ruled out. From 
a zoonotic point of view, it is well known that 
transmission from cattle/small ruminants 
to humans occurs via direct contact with 
viraemic blood or infectious abortion products, 
depending on the pathogenicity of the PPRV 
lineage and strain. Experimental infections 
with an Ethiopian goat strain of PPRV 
(CIRAD, unpublished data) in a small number 
of dromedaries in Dubai did not produce 
any clinical signs, suggesting that PPRV 
pathogenicity is low (Wernery, 2011). However, 
PPR disease is known to be extremely difficult 
to reproduce experimentally even in sheep and 
goats with the same degree of clinical signs as 
seen under field conditions. Wernery (2011) 
asserts that “there is a need for further infection 
trials with different PPR strains to elucidate the 
role of camels in the epidemiology of PPR”. 
PPR is considered a major threat for vulnerable 
rural populations in the post-rinderpest era in 
low-income countries. As a consequence, PPR 
is one of the transboundary animal diseases 
(TADs) that have been widely considered a 
priority for eradication. OIE and FAO have 
recently developed a global strategy for the 
control of PPR and ultimately its eradication 
(FAO, 2015;4 OIE, 2015).5 The ecological 
and epidemiological roles of unusual hosts, 
including wildlife and camels, need to be 
investigated and addressed in this context 
(Wohlsein and Singh, 2015).
The role of camels in PRRV ecology and 
PPR epidemiology is largely unknown and 
the limited information available points to a 
similar role to that played by cattle or wild 
ungulate species. PPRV does not appear 
to be maintained in the camel population 
alone. Infection in camels may be dependent 
on concomitant PPRV infection in small 
ruminants. In Morocco, in regions where there 
was no PPR in small ruminants, dromedaries 
were free of antibodies (Touil et al., 2012). 
However, their susceptibility to PPRV infection 
raises the question of whether camels have 
the potential to excrete the virus and, if so, 
for how long. This might suggest a potential 
role of camels in the PPR pathosystem in 
situations where small ruminant populations 
are below the critical community size to 
maintain PPRV and the presence of camel 
populations could result in the creation of a 
maintenance community; or where the camel 
population, in interaction with small ruminant 
populations, could help amplify the virus, 
increasing the potential for virus evolution and 
spread. However, up to now, there are no data 
to support these hypotheses. 
The role of camel populations could vary 
Camels are used for long distance and desert transport
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about the long-distance transportation of 
viruses. In numerous countries, particularly in 
Central Asia, epidemiological investigations 
are not conducted or published, making virus 
mapping particularly crude.
Serological tests should be developed 
and adapted to camelids before being 
evaluated and validated on field samples 
through epidemiological and modelling 
approaches such as receiver operating 
characteristic (ROC) analysis and Bayesian 
statistics. Bearing in mind the ethical issues, 
to improve both assess to the clinical effects 
of viral infection and estimates of specific 
epidemiological parameters, experimental 
reproduction should be carried out in 
premises with high-level biosecurity.
Ecological studies using aggregated data 
may help to identify drivers and determinants 
of disease/infection on a broad scale. When 
joined with spatial multi-criteria decision 
analyses (MCDAs), such studies would 
facilitate risk mapping. Modelling could 
help to explain the role of camels within 
socio-ecosystems and to forecast the risk 
of disease extension in time and space by 
using data on migration and trade. Contact 
networks at diverse scales among camels, 
other livestock and human populations 
should also be modelled using social network 
analysis (SNA) approaches. 
Finally, instead of working at the mono-
species scale, it is critical to widen the window 
and study the global community – domestic and 
wild animals and humans – within ecosystems 
(Faye, Waltner-Toews and McDermott, 1999; 
Caron et al., 2013). There is a clear need for 
integrated studies that cover health, economic 
and social issues in the relationships between 
people and camels and their environments 
to enable the highlighting and prediction of 
sanitary risks that new contexts might trigger.
CONCLUSION
Because the ecology and health of camelids 
are poorly documented, the consequences 
of global changes regarding dromedary and 
Bactrian camels are a new focus of scientific 
attention. The emergence of new pathogens 
has been increasing recently, most probably 
because of anthropogenic-related factors 
(Morse et al., 2012). The camel industry 
is in transition from nomadism to intensive 
production on the fringes of growing cities 
in Middle East, Africa and parts of Asia. 
These new host densities and the related 
human–animal interactions create favourable 
conditions for existing or new viruses to 
prosper and emergent ones to appear. The 
position of camels within pathosystems 
and episystems – as common or unusual 
hosts, victims or reservoirs for endemic or 
emerging infectious diseases – requires 
more attention from the donor and scientific 
communities. 360
impact on the health of camel populations, 
and of humans and other livestock.
Camel movements are considerable but 
are not properly quantified (Alary and Faye, 
2009). For example, estimating the numbers 
of animals involved and the frequency/
seasonality of migratory routes from sub-
Saharan countries to northern Africa, from 
eastern to western Africa, or from the Horn 
of Africa to the Arabian Peninsula would 
be a critical element of epidemiological 
investigations, risk analyses and surveillance 
implementation. Mapping of camel densities 
and movements (migration and trade) at finer 
spatial scales, as has been done for other 
livestock species, would be important to the 
design of health management programmes. 
There is also a severe lack of information on 
farming practices (herd sizes, grazing and 
water practices) and lifestyles (nomadic, 
sedentary and mixed) among human societies 
in the Arabian Peninsula and Africa.
Monitoring and surveillance systems in the 
field and at abattoirs should be boosted and 
are needed for endemic virus investigations 
(e.g. PPR, RVF), but also to detect new, 
potentially zoonotic pathogens (e.g. MERS-
CoV). They might provide significant 
information on disease patterns and allow 
pathogens to be isolated. Cross-sectional 
studies are generally carried out, but case 
control and cohort studies are better options 
for determining and quantifying risk and 
protective factors. 
When working with data gaps and 
frequently small sample sizes, rigorous 
analysis of the results is needed to depict the 
real picture. To overcome restraints, well-
designed surveillance, monitoring, ecological 
and epidemiological surveys and studies 
could provide adequate (representative) 
and sufficient (of statistical power) data 
and samples for epidemiology and virology 
work, including genomic analyses. Exploring 
the virome of camelids by metagenomics 
would help improve understanding of the 
associated pathological conditions and 
assessment of the risk of emergence and 
transmission to other species, including 
humans. Molecular epidemiology and 
phylogeography could feed hypotheses 
but there is as yet no specific information 
about transmission from dromedary camels to 
humans. It would be worthwhile to explore the 
sociological and economic impacts of RVF on 
camel production through a comprehensive 
approach. 
DISCUSSION
The roles of camels in the three viral infections 
presented are still largely unclear. Filling these 
gaps in knowledge is important, not only from 
a public and animal health perspective, but 
also from a socio-economic one. The cultural 
and increasing socio-economic importance 
of camel rearing in some societies makes 
the human populations involved highly 
vulnerable to any disturbance to camel health, 
production and the derived economy. For 
example, associating camels as a source of a 
zoonotic disease could put at risk the camel-
based socio-economy and camels’ viability as 
a source of livelihood for some populations. 
The most important knowledge gap is in 
the particular role, if any, that camels play in 
the epidemiology of these viral infections, 
especially regarding whether they maintain 
any of the infections. It is important to 
understand whether camels harbour specific 
strains or just receive strains from other hosts 
that are more crucial in maintenance of the 
pathogen, and the pathological and economic 
impacts of these infections on camel 
production. In some ecosystems, the high 
density of camels may create the conditions 
for them to amplify viral circulation among 
other livestock species, thereby increasing 
the likelihood of transmission to alternative 
hosts such as humans. Even if the capacity 
of camels to excrete the virus is small, they 
may play a role in bridging the gap between 
maintenance hosts (small ruminants, cattle, 
bats, etc.) and target hosts (humans, small 
ruminants). The particularities of camels and 
the specific culture and associated human 
behaviour involved in their rearing can create 
transmission pathways linked to the camelid–
human relationship, offering specific routes 
of spillover for viruses (e.g. among human 
societies in the Arabian Peninsula and Africa). 
As camels are used for trade (in desert 
caravans in the past, and mainly as live 
exports for the meat market today), they 
connect distant human populations and 
their livestock and may play a role in the 
large-scale dissemination of viruses if the 
viruses can survive in the host populations 
during transport. The oasis systems on which 
animals and humans rely for drinking-water 
are thus considered hotspots for pathogen 
transmission, and favour the exchange of 
parasites (virus, bacteria) between hosts. 
Extreme climatic events associated with 
climate change, which cause long periods 
of drought followed by short but severe 
downpours or floods, may also have a severe 
The most 
important knowledge 
gap is in the particular 
role, if any, that camels 
play in the epidemiology 
of these viral   
infectious 
empres-animal health 360  |  NO. 46/2016
8
Morse, S.S., Mazet, J.A., Woolhouse, M., Parrish, 
C.R., Carroll, D., Karesh, W.B., Zambrana-Torrelio, 
C., Lipkin, W.I. & Daszak, P. 2012. Prediction and 
prevention of the next pandemic zoonosis. The Lancet, 
380(9857): 1956–1965.
Muller, M.A., Corman, V.M., Jores, J., Meyer, B., 
Younan, M., Liljander, A., Bosch, B.J., Lattwein, 
E., Hilali, M., Musa, B.E., Bornstein, S. & Drosten, 
C. 2014. MERS coronavirus neutralizing antibodies 
in camels, Eastern Africa, 1983–1997. Emerg. Infect. 
Dis., 20(12): 2093–2095.
OIE. 2015. Towards global eradication of peste des 
petits ruminants. Available at: http://www.oie.int/en/
for-the-media/editorials/detail/article/towards-global-
eradication-of-peste-des-petits-ruminants/ 
Olaleye, O.D., Tomori, O. & Schmitz, H. 1996. Rift 
Valley fever in Nigeria: infections in domestic animals. 
Rev. Sci. Tech. Off. Int. Epiz., 15: 937–946.
Rajneesh, Kataria, A.K. & Tanwar, R.K. 2011. 
Prevalence of some infectious diseases in dromedary 
camel from Bikaner region in Rajasthan. Vet. Pract., 
12(1): 50–53.
Reusken, C.B.E.M., Haagmans, B.L., Mueller, 
M.A., Gutierrez, C., Godeke, G.-J., Meyer, B., 
Muth, D., Raj, V.S., Smits-De Vries, L., Corman, 
V.M., Drexler, J.-F.,  Smits, S.L., El Tahir, Y.E., 
De Sousa, R., van Beek, J., Nowotny, N., van 
Maanen, K., Hidalgo-Hermoso, E., Bosch, B.-J., 
Rottier, P., Osterhaus, A., Gortázar-Schmidt, C., 
Drosten, C. & Koopmans, M.P.G. 2013. Middle 
East respiratory syndrome coronavirus neutralising 
serum antibodies in dromedary camels: a comparative 
serological study. Lancet Infect. Dis., 13(10): 
859–866.
Reusken, C.B., Messadi, L., Feyisa, A., Ularamu, 
H., Godeke, G.J., Danmarwa, A., Dawo, F., 
Jemli, M., Melaku, S., Shamaki, D., Woma, Y., 
Wungak, Y., Gebremedhin, E.Z., Zutt, I., Bosch, 
B.J., Haagmans, B.L. & Koopmans, M.P.G. 2014. 
Geographic distribution of MERS coronavirus among 
dromedary camels, Africa. Emerg. Infect. Dis., 20(8): 
1370–1374.
Roger, F., Guebre Yesus, M., Libeau, G., Diallo, 
A., Yigezu, L.M. & Yilma, T. 2001. Detection of 
antibodies of rinderpest and peste des petits ruminants 
viruses (Paramyxoviridae, Morbillivirus) during a new 
epizootic disease in Ethiopian camels (Camelus 
dromedarius). Rev. Méd. Vét., 152(3): 265–268.
Swai, E.S. & Sindato, C. 2015. Seroprevalence of 
Rift Valley fever virus infection in camels (dromedaries) 
in northern Tanzania. Trop. Anim. Health Prod., 47(2): 
347–352.
Touil, N., Cherkaoui, Z., Lmrabih, Z., Loutfi, 
C., Harif, B. & El Harrak, M. 2012. Emerging 
viral diseases in dromedary camels in the Southern 
Morocco. Transb. Emerg. Dis., 59(2): 177–182.
Wernery, U. 2011. Peste des petits ruminants (PPR) 
in camelids with own investigation. J. Camel Pract. and 
Res., 18(2): 219–223.
Wohlsein, P. & Singh, R.P. 2015. Peste des petits 
ruminants in unusual hosts: epidemiology, disease, and 
impact on eradication. In Peste des petits ruminants 
virus, pp. 95–118. Heidelberg, Germany, Springer 
Berlin. 
Woma, T.Y., Kalla, D.J., Ekong, P.S., Ularamu, 
H.G., Chollom, S.C., Lamurde, I.I., Bajehson, D.B., 
Tom, N.D., Aaron, G.B., Shamaki, D., Bailey, D., 
Diallo, A. & Quan, M. 2015. Serological evidence 
of camel exposure to peste des petits ruminants virus 
(PPRV) in Nigeria. Trop. Anim. Health Prod., 47(3): 
603–606.
Yigezu, L.M., Roger, F., Kiredjian, M. & Tariku, S. 
1997. Isolation of Streptococcus equi subspecies equi 
(strangles agent) from an Ethiopian camel. Vet. Rec., 
140(23): 608.
El-Harrak, M., Martín-Folgar, R., Llorente, F., 
Fernández-Pacheco, P., Brun, A., Figuerola, J. 
& Jiménez-Clavero, M.A. 2011. Rift Valley and West 
Nile virus antibodies in camels, North Africa. Emer. 
Infect. Dis., 17(12): 2372–2374.
El Mamy, A.B., Baba, M.O., Barry, Y., Isselmou, 
K., Dia, M.L., El Kory, M.O., Diop, M., Lo, 
M.M., Thiongane, Y., Bengoumi, M., Puech, 
L., Plee, L., Claes, F., de La Rocque, S. & Doumbia, 
B. 2011. Unexpected Rift Valley fever outbreak, 
northern Mauritania. Emerg. Infect. Dis., 17(10): 
1894–1896.
FAO. 2015. empres360 animal health, 45.
Faye, B. 2015. Role, distribution and perspective of 
camel breeding in the third millennium economies. Emir. 
J. Food Agric., 27(4): 318–327.
Faye, B., Chaibou, M. & Vias, G. 2012. Integrated 
impact of climate change and socioeconomic 
development on the evolution of camel farming systems. 
Brit. J. Environ. Clim. Change, 2(3): 227–244.
Faye, B., Waltner-Toews, D. & McDermott, J. 1999. 
From “ecopathology” to “agroecosystem health”. Prev. 
Vet. Med., 39(2): 111–128.
Gossner, C., Danielson, N., Gervelmeyer, A., 
Berthe, F., Faye, B., Kaasik Aaslav, K., Adlhoch, 
C., Zeller, H., Penttinen, P. & Coulombier, D. 2016. 
Human–dromedary camel interactions and the risk of 
acquiring zoonotic Middle East respiratory syndrome 
coronavirus infection. Zoonoses and Public Health, 
63(1): 1–9. Available at: http://onlinelibrary.wiley.com/
doi/10.1111/zph.12171/full
Haroun, M., Hajer, I., Mukhtar, M. & Ali, B.E. 
2002. Detection of antibodies against peste des petits 
ruminants virus in sera of cattle, camels, sheep and 
goats in Sudan. Vet. Res. Commun., 26(7): 537–541.
Imam, I.Z., El-Karamany, R. & Darwish, M.A. 1979. 
An epidemic of Rift Valley fever in Egypt. 2. Isolation 
of the virus from animals. Bull. World Health Organ., 
57(3): 441–443.
Ithinji, D.G. 2011. Peste des petits ruminants 
manifestation in sheep and goats and its prevalence 
in incontact herbivores in Kenya. Nairobi, Kenya, 
University of Nairobi. (M.Sc. thesis)
Khalafalla, A.I., Saeedb, I.K., Ali, Y.H., 
Abdurrahmanb, M.B., Kwiatekc, O., Libeauc, 
G., Obeidaa, A.A. & Abbas, Z. 2010. An outbreak 
of peste des petits ruminants (PPR) in camels in the 
Sudan. Acta Tropica, 116(2): 161–165.
Liljander, A., Meyer, B., Jores, J., Müller, M.A., 
Lattwein, E., Njeru, I., Bett, B., Drosten, C. & 
Corman, V.M. 2016. MERS-CoV antibodies in 
humans, Africa, 2013–2014. Emerg. Infect. Dis., 22(6): 
doi 10.3201/eid2206.160064.
Mackay, I.M. & Arden, K.E. 2015. Middle East 
respiratory syndrome: An emerging coronavirus infection 
tracked by the crowd. Virus Research, 202: 60–88.
Mariner, J.C., Morrill, J. & Ksiazek, T.G. 1995. 
Antibodies to hemorrhagic fever viruses in domestic 
livestock in Niger: Rift Valley fever and Crimean-Congo 
hemorrhagic fever. Am. J. Trop. Med. Hyg., 53(3): 
217–221.
Miguel, E., Perera, A.P.M., Baubekova, A., 
Chevalier, V., Faye, B., Akhmetsadykov, N., Ng, 
C.Y., Roger, F. & Kayali, G. 2016. Absence of Middle 
East respiratory syndrome coronavirus in camelids, 
Kazakhstan, 2015. Emerg. Infect. Dis., 22(3): letter 
March 2016.
Mohammed, O.B., Alagaili, A.N., Sandouka, M.A., 
Omer, S.A., Elamin, M.H. & Abu Elzein, E.M.E. 
2013. Serosurveillance for some diseases in livestock 
living within protected areas designated for wildlife 
reintroduction in Saudi Arabia. Afr. J. Microbiol. Res., 
7(16): 1574–1578.
REFERENCES
Abraham, G., Sintayehu, A., Libeau, G., Albina, E., 
Roger, F., Laekemariam, Y., Abayneh, D. & Awoke, 
K.M. 2005. Antibody seroprevalences against peste 
des petits ruminants (PPR) virus in camels, cattle, goats 
and sheep in Ethiopia. Prev. Vet. Med., 70(1 –2): 51–57.
Albayrak, H. & Gür, S. 2010. A serologic investigation 
for peste des petits ruminants infection in sheep, cattle 
and camels (Camelus dromedarius) in Aydin province, 
West Anatolia. Trop. Anim. Health Prod., 42(2): 
151–153.
Alary, V. & Faye, B. 2009. Overview of the camel 
chains in East of Africa: importance of gaps between 
the data and the apparent reality. Proceedings of the 
Second Conference of the International Society of 
Camelid Research and Development, abstract 92, p. 
74. Djerba, Tunisia, 12–14 March 2009. 
Boussini, H., Lamien, C.E., Nacoulma, O.G. & 
Ouedraogo, A. 2013. Rift Valley fever in camels in 
northern Burkina Faso. Bull. Anim. Health Prod. Afr., 61(3).
Britch, S.C., Binepal, Y.S., Ruder, M.G., Kariithi, 
H.M., Linthicum, K.J., Anyamba, A., Small, 
J.L., Tucker, C.J., Ateya, L.O., Oriko, A.A., Gacheru, 
S. & Wilson, W.C. 2013. Rift Valley fever risk map 
model and seroprevalence in selected wild ungulates 
and camels from Kenya. PloS One, 8(6).
Caron, A., Miguel, E., Gomo, C., Makaya, P., 
Pfukenyi, D.M., Foggin, C., Hove, T. & de Garine-
Wichatitsky, M. 2013. Relationship between burden 
of infection in ungulate populations and wildlife/livestock 
interfaces. Epid. Inf., 141(7): 1522–1535.
Chan, R.W., Hemida, M.G., Kayali, G., Chu, D.K., 
Poon, L.L., Alnaeem, A., Ali, M.A., Tao, K.P., Ng, 
H.Y., Chan, M.C., Guan, Y., Nicholls, J.M. & Peiris, 
J.S. 2014. Tropism and replication of Middle East 
respiratory syndrome coronavirus from dromedary 
camels in the human respiratory tract: an in-vitro and ex-
vivo study. Lancet Respir. Med., 2(10): 813–822.
Chan, S.M., Damdinjav, B., Perera, R.A., Chu, D.K., 
Khishgee, B., Enkhbold, B., Poon, L.L. & Peiris, 
M. 2015. Absence of MERS-coronavirus in Bactrian 
camels, Southern Mongolia, November 2014. Emerg. 
Infect. Dis., 21(7): 1269–1271.
Chevalier, V. 2013. Relevance of Rift Valley fever to 
public health in the European Union. Clin. Microbiol. 
Infect., 19(8): 705–708.
Corman, V.M., Jores, J., Meyer, B., Younan, M., 
Liljander, A., Said, M.Y., Gluecks, I., Lattwein, E., 
Bosch, B.-J., Drexler, J.F., Bornstein, S., Drosten, 
C. & Müller, M.A. 2014. Antibodies against MERS 
coronavirus in dromedary camels, Kenya, 1992–2013. 
Emerg. Infect. Dis., 20(8): 1319–1322.
Dawo, F. 2014. Mysterious mortality in camels 
(Camelus dromedarius) in Borana, Ethiopia: Evidence 
of its association with reproductive age groups. Rev. 
Sci. Tech. Off. Int. Epiz., 29(3): 621–628. 
Di Nardo, A., Rossi, D., Saleh, S.M., Lejlifa, 
S.M., Hamdi, S.J., Di Gennaro, A., Savini, G. 
& Thrusfield, M.V. 2014. Evidence of Rift Valley fever 
seroprevalence in the Sahrawi semi-nomadic pastoralist 
system, Western Sahara. BMC Vet. Res., 10: 92.
Dudas, G. & Rambaut, A. 2015. MERS-CoV 
recombination: implications about the reservoir 
and potential for adaptation. bioRxiv, http://dx.doi.
org/10.1101/020834.
Eisa, M. 1984. Preliminary survey of domestic animals 
of the Sudan for precipitating antibodies to Rift Valley 
fever virus. J. Hyg. (Lond.), 93(3): 629–637.
El-Dakhly, A.T. 2015. Serological survey for peste 
des petits ruminants virus (PPRv) in camel from 
different regions in the west of Libya. Int. J. Sci. Res., 
4(3): 1455–1459.
9empres-animal health 360  |  NO. 46/2016
activities, the number of reported HAT cases 
has decreased substantially over the last 
15 years. Nevertheless, in 2012, 70 million 
people were estimated to be at risk of HAT 
infection. 
The control and eventual elimination 
of human and animal trypanosomoses 
would significantly contribute to increased 
productivity of land and livestock, improved 
human health and reduced poverty in rural 
Africa. The Comprehensive Africa Agriculture 
Development Programme (CAADP) of the 
New Partnership for Africa’s Development 
(NEPAD) recognizes trypanosomoses as 
the main constraint in areas that have the 
greatest opportunities for expansion of 
livestock agriculture. CAADP also emphasizes 
the significant role that mixed crop–livestock 
systems could play in vast areas of the African 
continent if the burden of trypanosomoses 
were reduced. Such mixed crop–livestock 
systems include those of the cotton belt in 
West Africa and the southern Rift Valley of 
Ethiopia.
Early and correct diagnosis of 
trypanosomal infection in livestock is the basis 
for efficient treatment. Despite the significant 
progress made in past years in improving 
disease diagnostic methods, the techniques 
currently used in the field still suffer from low 
specificity and low sensitivity. This situation 
results in drug administration being delayed 
until treatment is no longer effective, with 
consequent deaths of animals. Delayed 
treatment also results in increased losses in 
milk, meat and draught power and increased 
infertility.
There is no vaccine against the 
Trypanosoma spp. disease complex. Therefore, 
along with the control of tsetse vectors, 
chemotherapy of livestock with trypanocides 
is by far the most widely used method of 
reducing the impact of animal trypanosomoses 
in sub-Saharan Africa. However, resistance to 
This article is based on a presentation at 
the International Society for Neglected 
Tropical Diseases, London, United Kingdom 
of Great Britain and Northern Ireland, 
March 2015. 
African trypanosomoses are a family of parasitic diseases that are unique to Africa, affect both humans and 
animals and are transmitted by tsetse flies 
(Glossina spp.). The diseases occur across 
about 9 million km2 in 39 sub-Saharan 
countries, corresponding to almost one-third 
of Africa’s total land area. Losses in the 
livestock sector include deaths, abortions, 
infertility, weight loss and reduced draught 
power and milk production, all of which 
have an impact on people’s livelihoods. 
FAO estimates that direct losses to African 
trypanosomoses in livestock exceed US$1.5 
billion a year. More broadly, trypanosomoses 
reduce agricultural income by approximately 
US$4.5 billion a year by limiting or preventing 
the utilization of land with high potential for 
agricultural production and by constraining 
the diversification of crop–livestock 
production systems. These economic 
losses are compounded by the impacts of 
trypanosomosis on human health and by 
complex socio-cultural and food insecurity 
dimensions. It is therefore no coincidence that 
of the 39 tsetse-infested countries, 32 are 
low-income, food-deficit countries and 29 are 
least developed countries. 
Human African trypanosomiasis (HAT), 
also known as sleeping sickness, is a 
devastating and lethal disease that affects 
mainly isolated populations in rural areas. As 
a result of reinforced control and surveillance 
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To this end, it is essential to integrate 
techniques for tsetse and trypanosomoses 
control into existing agricultural practices, 
taking into consideration the overall 
context of sustainable agricultural and rural 
development.
Given the geographical scale of the 
problem and its complex and dynamic 
medical, veterinary, agricultural, environmental 
and rural development dimensions, Member 
Nations of FAO have recognized the need to 
focus and direct the fight against tsetse and 
trypanosomoses. For example, in 1997, the 
Programme Against African Trypanosomosis 
(PAAT) was established by the 29th FAO 
Conference (Resolution 5/1997). PAAT 
provides the umbrella for international 
alliances and inter-agency collaboration, 
and its Secretariat comprises FAO, IAEA, 
WHO and the African Union (AU), through 
its Interafrican Bureau for Animal Resources 
(AU-IBAR). Through PAAT, FAO deals with 
the constraints that trypanosomosis poses to 
agricultural production, rural development and 
food security. FAO also hosts the focal point 
of the PAAT Secretariat. WHO is responsible 
for managing issues arising from the human 
the veterinary trypanocides currently available 
is increasing, and no new therapeutic or 
prophylactic drugs are expected in the next 
few years. The lack of efficacy of treatment and 
the development of resistance are exacerbated 
by frequent under-dosing and/or poor-quality 
veterinary products with low concentrations 
of active principle. In addition, trypanosomal 
infections have an immune-suppressive 
effect, rendering animals more susceptible 
to concurrent diseases and/or impairing an 
effective immune response to vaccination 
against other diseases (e.g. brucellosis, 
haemorrhagic septicaemia, foot-and-mouth 
disease, peste des petits ruminants).
Concerning the human health dimension, 
correct and timely diagnosis of cases is a 
key element of the control strategy, which 
is based mainly on the detection and 
subsequent treatment of infected individuals. 
While important progress has recently been 
made in the treatment of HAT, the tools used 
for screening and diagnosis have not changed 
much in decades. In addition, while access to 
drugs is guaranteed through manufacturers’ 
donations to the World Health Organization 
(WHO), the lack of funding mechanisms to 
ensure access to screening and diagnosis is 
another cause of concern.
Across sub-Saharan Africa, the socio-
economic impact of trypanosomoses 
varies within and among countries, regions 
and agro-ecological zones. An accurate 
understanding of the causal relationship 
between poverty and the development 
constraints related to trypanosomoses is 
therefore crucial. Interventions against the 
diseases and their vectors (tsetse flies) are 
likely to yield maximum economic returns 
and growth if adequately embedded in 
broader national and/or regional policies 
for the development of livestock agriculture. 
form of the disease and the related public 
health dimensions; various resolutions of 
the World Health Assembly over the last 
15 years have urged WHO to strengthen 
disease control and to aim at elimination. 
IAEA is involved through the Vienna-based 
Joint FAO/IAEA Division, and its main focus 
areas include disease epidemiology and the 
development and integration of the sterile 
insect technique as a component of area-wide 
integrated pest management programmes 
aiming at the progressive creation, expansion 
and maintenance of tsetse-free areas. 
PAAT’s vision is of an African continent 
where trypanosomoses no longer constrain 
sustainable agricultural and rural development 
or threaten human health. Its mission is 
to assist countries affected by tsetse and 
trypanosomoses by promoting sustainable 
agricultural and rural development and human 
health through partnerships and coordinated 
efforts. 
Within the remits of their respective 
mandates and competencies, PAAT 
members have provided joint technical 
assistance to countries affected by African 
trypanosomoses for more than 15 years. 
PAAT also supports the AU’s Pan African 
Tsetse and Trypanosomosis Eradication 
Campaign (PATTEC), which was established 
in July 2000 by a decision of the Heads of 
State and Government of the Organization of 
African Unity, now the AU, with the mandate 
of progressively creating, expanding and 
maintaining tsetse-free areas. 
PAAT is a broad international forum that 
seeks to bring together all actors concerned 
with tsetse fly and African trypanosomosis 
research, control and elimination. It provides 
expertise on various aspects of tsetse and 
disease management, and the associated 
issues of land use, environmental protection 
and sustainable livestock-agricultural and 
socio-economic development. The support 
that PAAT provides to tsetse-affected 
countries translates into coordinated actions 
and collaboration at the international, regional 
and national levels. PAAT also engages with 
research organizations in applied research 
and development activities. 
Recent achievements of PAAT have 
included the development and application 
of novel technologies for improved animal 
health and production and of internationally 
agreed standards for the quality control of 
trypanocidal drugs.
The novel technologies that have been 
developed and promoted include the 
livestock protective fence (LPF), which 
involves the simple but innovative use of 
insecticide-impregnated nets to protect 
livestock. The technology is capable of 
doubling and in some cases tripling milk 
outputs on smallholder dairy farms, while 
also reducing mosquito-borne illnesses in 
Small-scale cattle fattening and beef finishing in a tsetse-controlled area, southern Ethiopia
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to strengthening and sustaining efforts for 
disease elimination. 
The PAAT Information System (PAAT-IS) is 
a key component of PAAT that plays a crucial 
role in health surveillance at the continental 
level by integrating data on humans, livestock 
and vectors. PAAT-IS comprises a range of 
open-access resources, including maps, 
technical and scientific monographs and 
a biannual bulletin focusing on news and 
scientific advances in the field of tsetse 
and trypanosomoses. Two internationally 
coordinated data management initiatives 
are ongoing within the PAAT-IS framework: 
the atlas of HAT and the atlas of tsetse and 
African animal trypanosomosis (AAT). 
The atlas of HAT was launched in 2007 
by WHO and is jointly implemented by FAO 
with the support of WHO Member Nations 
(Simarro et al., 2010). Its primary objectives 
are to map, at the village level, all cases of 
sleeping sickness in endemic areas of sub-
Saharan Africa and all screening activities 
(from 2000 onwards), and to build capacity 
at the country level for optimal utilization 
and regular updating of the atlas (Cecchi et 
al., 2009). The main outputs of the initiative 
are maps of HAT distribution and risk at the 
continental, regional, national and focus level 
(Simarro et al., 2010; 2012a; 2015), as 
shown in Figure 1. Other products include 
continental maps of health facilities involved 
in HAT treatment and surveillance (Simarro 
et al., 2014) and global maps of HAT in non-
endemic countries (Simarro et al., 2012b). 
The atlas of HAT has become an authoritative 
laboratory in Dar es Salaam, United Republic 
of Tanzania – which now serve as reference 
institutions for their respective regions.
In Senegal, IAEA is supporting a project 
that aims to eradicate an isolated population 
of Glossina palpalis gambiensis in the 
Niayes area, near Dakar. The removal of 
trypanosomosis will eliminate the need for 
constant prophylactic treatment of cattle with 
trypanocidal drugs, thereby reducing residues 
of these drugs in the animals’ dung, meat and 
milk. The main beneficiaries of the project are 
many smallholder farmers, larger commercial 
farms and the consumers of meat and milk. 
After eradication of the tsetse fly, farmers 
will be able to replace their local breeds with 
improved breeds and increase their annual 
income by €2.8 million (Bouyer et al., 2014). 
At the same time, the cattle population will 
be reduced by 45 percent, which will result in 
reduced environmental impacts.
Concerning HAT, WHO provides support 
and technical assistance to national control 
programmes to strengthen disease control 
and surveillance in endemic countries. 
Access to treatment is ensured through 
public–private partnerships with Sanofi and 
Bayer HealthCare, which enable WHO to 
supply all the required anti-trypanosome 
medicines free of charge. The efforts of 
WHO, national control programmes, bilateral 
cooperation partners and non-governmental 
organizations have made elimination of the 
disease as a public health problem by 2020 
a possible target. In 2014, WHO established 
a coordination network for HAT with a view 
humans. The nets are environmentally safe 
and they drastically cut the numbers of flies, 
mosquitoes and other disease-transmitting 
insect vectors by up to 90 percent. Cases 
of mastitis, which can be spread by flies 
and poor hygiene during milking, can also 
be halved on smallholder dairy farms. 
Smallholder pig farmers using LPFs in a 
coastal area infested by tsetse flies in Ghana 
substantially reduced trypanosomosis 
prevalence in their pigs and the associated 
mortality of piglets. Pig farmers using LPFs 
also obtain higher prices for their animals 
on the market. Careful management and 
monitoring of the expanding use of LPFs will 
be required to avoid the rapid development 
of resistance in certain populations/species 
of insect and arthropod.
Activities to promote the quality control of 
trypanocidal drugs include the establishment 
of an international alliance among FAO, the 
World Organisation for Animal Health (OIE), 
the Global Alliance for Livestock Veterinary 
Medicines (GALVmed), IAEA, the International 
Federation for Animal Health (IFAH) and 
the University of Strathclyde in the United 
Kingdom of Great Britain and Northern 
Ireland, and the development of knowledge 
and analytical procedures on quality control 
and quality assurance of trypanocides for 
publication in an international scientific journal 
(Sutcliffe et al., 2014). This knowledge is being 
applied in two laboratories – the Laboratoire 
de Contrôle des Médicaments Vétérinaires 
(LACOMEV) in Dakar, Senegal, and the 
Tanzania Food and Drugs Authority (TFDA) 
Figure 1: Risk of human African trypanosomosis, 2008–2012
Source: Adapted from Franco et al., 2015.
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reference for all practitioners, scientists and 
policy-makers involved in the control and 
elimination of HAT. It also represents an 
indispensable tool for planning, implementing 
and monitoring HAT elimination activities.
In 2010, the success of the HAT atlas 
motivated FAO to launch the atlas of tsetse 
and AAT, which aims to collate, analyse and 
disseminate comprehensive and up-to-date 
information on the occurrence and distribution 
of tsetse and AAT. This is a FAO-led initiative 
jointly implemented with IAEA in support of 
AAT-affected countries. At the continental 
level, the atlas relies on data published 
in scientific journals, which are extracted, 
georeferenced and inserted into a database. 
Methodologies and preliminary results for 
Ethiopia, Kenya and Uganda have recently 
been published (Cecchi et al., 2014; 2015), 
and are summarized in Figure 2. In addition to 
the continental atlas based on publications, 
FAO and IAEA support affected countries 
in building national atlases, which rely on 
the sometimes vast amounts of unpublished 
information available at the national level.
Geospatial information from the atlases 
of HAT, tsetse and AAT also enables 
integrated epidemiological analyses of the 
human, livestock, vector and environmental 
components.
Capacity building is another essential 
activity carried out through PAAT. Over 
the years, hundreds of staff members from 
trypanosomosis-affected countries have 
been trained in different aspects of tsetse 
Figure 2: Reported occurrence of tsetse flies (Genus: Glossina) and African animal 
trypanosomosis in Ethiopia, Kenya and Uganda, as published in the scientific literature 
Data collected January 1990 to December 2014. 
Sources: Adapted from Cecchi et al., 2014 and 2015. 
• Programme Against African Trypanosomosis (PAAT)
• FAO/IAEA Programme: Insect Pest Control
• World Health Organization – Human African trypanosomiasis
• Pan African Tsetse and Trypanosomiasis Eradication Campaign
Further information on the various initiatives
Identifying cases of human African trypanosomosis in a rural area of Chad
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of fixed health facilities to cover people at risk of 
gambiense human African trypanosomiasis. Int. J. 
Health Geogr., 13: 4.
Simarro, P.P., Cecchi, G., Franco, J.R., Paone, M., 
Diarra, A., Priotto, G., Mattioli, R.C. & Jannin, J.G. 
2015. Monitoring the progress towards the elimination 
of gambiense human African trypanosomiasis. PLoS 
Negl. Trop. Dis., 9(6): e0003785.
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a continental atlas of the distribution and 
trypanosomal infection of tsetse flies (Glossina 
species). Parasites and Vectors, 8: 284.
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Diarra, A., Priotto, G., Mattioli, R., Simarro, 
P.P. & Jannin, J.G. 2015. Putting the elimination 
of human African trypanosomiasis on the map: 
achievements and challenges. Abstracts of the 
9th European Congress on Tropical Medicine 
and International Health, Basel, Switzerland, 
6–10 September 2015. Trop. Med. Int. Health, 
20(suppl. 1): 167. Available at http://onlinelibrary.
wiley.com/doi/10.1111/tmi.12573/pdf 
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of human African trypanosomiasis: a contribution to 
global mapping of neglected tropical diseases. Int. 
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and trypanosomosis control and elimination. 
Expertise is drawn from the United Nations 
(UN) specialized agencies and other PAAT 
partners, and the PAAT framework ensures 
harmonization and maximization of synergies.
Beyond its specific technical 
achievements, PAAT also facilitates 
effective inter-agency collaboration within 
the UN system and with other international 
institutions, which can be a powerful force for 
innovation and development. 360
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ESTABLISHMENT OF THE 
FIELD EPIDEMIOLOGY 
TRAINING PROGRAMME FOR 
VETERINARIANS 
In 2008, the Emergency Centre for 
Transboundary Animal Disease Operations 
(ECTAD) at FAO’s Regional Office for Asia 
and the Pacific (RAP) started to implement a 
systematic approach to assess and develop 
epidemiology capacity in the region. Having 
forged strong partnerships with Thailand’s 
Department of Livestock Development and 
Ministry of Public Health, FAO established 
a regional Field Epidemiology Training 
Programme for Veterinarians (FETPV). 
Contributing partners included the United 
States Agency for International Development 
(USAID) and other international donors 
such as the European Union (EU), the 
United States Centers for Disease Control 
and Prevention (CDC), the International 
Epidemiology Consortium, universities 
and participating countries in the region. 
FETPV is now a growing branch of the Field 
Epidemiology Training Programme (FETP) 
model run by national public health agencies 
in 55 countries since 1975.3 
The FETPV process starts with a 
consultative needs assessment involving 
country experts and national and international 
stakeholders and including a gap analysis of 
the 34 skills covered by the guidelines of the 
Training Programs in Epidemiology and Public 
Health Interventions Network (TEPHINET), 
adapted to veterinary needs. Based on the 
results of these assessments, curricula and 
learning objectives are designed for the 
national and sub-national levels, enabling 
countries to drive their own harmonized 
approaches to capacity development. The 
four main elements of the FETPV curriculum 
are: i) understanding of basic epidemiological 
Infectious disease intelligence is based 
on an understanding of epidemic patterns, 
including animal and zoonotic diseases, and 
the application of this knowledge to disease 
control. Disease intelligence is the result 
of: i) rapid and accurate identification of the 
disease agent; and ii) a clear understanding 
of the sample and its epidemiological 
context (animal, place and time parameters). 
Over the past decade, progress has been 
made in strengthening technical capacity 
and resources to build more effective 
epidemiological support and to improve 
disease intelligence. However, there are still 
very few qualified epidemiologists available. 
Without good-quality epidemiological 
information, it is not possible to determine the 
protective and risk factors associated with the 
frequency and distribution of diseases in a 
population of animals (or humans).
THE NEED FOR EPIDEMIOLOGY
Over the past decade, experiences of 
dealing with avian influenza and other high-
impact animal and zoonotic diseases in Asia 
have demonstrated that national veterinary 
authorities have often been forced to take 
difficult decisions about disease prevention 
and control in their countries without 
having access to essential epidemiological 
information. In some instances, before the 
veterinary services at the central level have 
conducted any investigations, the local 
authority has already given instructions for 
culling and disposing of diseased livestock, 
resulting in the loss of opportunities for 
collecting and disseminating epidemiological 
information to guide evidence-based decision-
making. There is a critical need for improved 
disease intelligence in every country in the 
region.
Field Epidemiology Training 
Programme for Veterinarians:  
strengthening disease intelligence on 
emerging and transboundary animal diseases
ADVANCES
Contributors: David Castellan,1  Kachen Wongsathapornchai,1  Bui Thuyha,1  Karoon Chanachai,2  Tippawon 
Prarakamawongsa,2  Wantanee Kalpravidh1
1 Food and Agriculture Organization of the United Nations (FAO), Regional Office for Asia and the Pacific, Emergency Centre for Transboundary Animal Disease Operations 
(ECTAD)
2  Department of Livestock Development, Thailand
3  http://www.tephinet.org
FETPV trainees conduct outbreak investigations under mentorship 
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fields; the Masters programme takes one to 
two years to complete. At this stage, in line 
with the principle of learning by providing 
services, trainees apply their epidemiological 
knowledge and skills to conduct field 
research at their home stations, supporting 
the functions of their respective institutions 
while under the close supervision of mentors 
from universities, the FETPV, FAO and the 
government units for which they work.
IMPACTS AND THE WAY 
FORWARD
By September 2015, 107 people in 12 
Asian countries had benefited from the 
regional FETPV. In a survey conducted in 
April 2015, 84 percent of respondents 
reported that knowledge gained through 
the FETPV had led to changes in their 
approaches to epidemiology at work: 90 
percent indicated improvements in the 
implementation of outbreak investigations; 
75 percent indicated improvements in 
the design, implementation and reporting 
of surveillance; 82 percent had used 
their new knowledge to inform or mentor 
colleagues, thereby improving the collection, 
management and analysis of data; and 23 
helping them to appreciate and respect each 
other’s professionalism and ethics. The first 
two modules, on surveillance and outbreak 
investigation, take approximately a year and 
a half to complete. Trainees learn about and 
apply epidemiology through a curriculum that 
is 30 percent training workshops and field 
demonstrations and 70 percent practical 
fieldwork. 
Trainees who complete the first two 
modules are then eligible for the third module, 
which is a Masters programme offered jointly 
by FAO and two universities in Thailand with 
M.Sc. programmes in epidemiology or related 
concepts and application of these concepts 
for: ii) surveillance; iii) outbreak investigation; 
and iv) communication of results to technical 
and non-technical stakeholders.
APPROACH AND CURRICULUM
The FETPV applies the principle of learning 
by providing services, which makes no 
distinction between learning about and 
working in epidemiology. Trainees both serve 
as they learn and learn as they serve in their 
respective governments’ core functions 
related to animal health and production. For 
example, since its inauguration in 2009, the 
regional FETPV curriculum has undergone 
several revisions following rigorous and 
comprehensive periodic evaluations. Currently 
the curriculum is divided into three inter-
related and sequential modules.  
The programme begins with a one-month 
introductory course on epidemiology, which is 
organized jointly by the FETPV and the FETP 
and is based on collaboration between animal 
and human health. During this introductory 
course, veterinarians and doctors are trained 
together, exposing them to the similarities and 
differences in epidemiological approaches 
to disease prevention and control and 
82 percent had 
used their new 
knowledge to inform 
or mentor colleagues, 
thereby improving 
the collection, 
management and 
analysis of data 
An FETPV trainee collects samples and field data as part of an outbreak investigation 
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epidemiology capacity conducted in 2014–
2015 estimated that national epidemiologists 
spent a maximum of 20 percent of their work 
time performing technical epidemiology duties 
directly related to their training. The return on 
training investment so far remains limited and 
requires additional institutional prioritization, 
accommodation and change. Each country 
needs a plan for linking the training to the 
post-training environment to obtain maximum 
benefits from the training of individual 
epidemiologists. Enhancing both the number 
of trained individuals and the quality of the 
training will be necessary to improve the 
targeting of investments and optimize outputs.
There is growing realization among 
countries in the region of the value of the 
FETPV as national programmes continue to 
develop. At this early stage, it is important to 
demonstrate the proof of concept, to facilitate 
high-level commitment from national authorities. 
The mentorship programme requires 
dedicated technical support from trainers and 
mentors with a good technical background 
in epidemiology, practical field experience, 
familiarity with government functions and the 
skills to nurture the valuable national human 
resources assigned to the programme. Building 
a critical mass of mentors is a key to success, 
so it is important to continue strengthening 
FETPV graduates – as potential future mentors 
– to ensure that they have opportunities to 
apply their acquired skills at work and to 
support their fellow trainees. In the 2015 
survey, between 9 and 47 percent of regional 
FETPV graduates reported various institutional 
challenges when applying their epidemiological 
knowledge at work. Institutional change is 
challenging but necessary to build, maintain 
and foster the development of a functional 
epidemiology capacity in the region. 360
network has been described as a “national 
treasure”, demonstrating the impact that it has 
had in a relatively short period.
Indonesia has also indicated the need 
for a national FETPV, following successful 
participation of Indonesian trainees in the 
regional FETPV since 2009. The country is 
carrying out a needs assessment to identify 
the core competencies, skill sets and 
resources required to establish and maintain 
such a programme. Based on a roadmap 
drawn up by core national stakeholders in 
June 2015, the first training course will be 
launched as the official inauguration of the 
Indonesia-FETPV in September 2016.
One of the most difficult challenges in 
developing this applied epidemiology training 
programme was in building institutional 
safeguards to enable trained individuals to 
apply their skills when they return to their 
workplaces. For example, four assessments of 
percent considered that their career paths 
improved after participating in the training.
The regional FETPV has been recognized 
by the Association of Southeast Asian Nations 
(ASEAN) as a platform for strengthening 
epidemiology capacity in the region and 
was a major catalyst in the development of 
ASEAN’s Strategic Framework for Veterinary 
Epidemiology Capacity Development and 
Networking (the Epi Framework), which was 
endorsed by ASEAN Ministers in 2013. 
The Epi Framework is complemented by 
establishment of the ASEAN Veterinary 
Epidemiology Group (AVEG). This recognition 
of the regional FETPV demonstrates its high-
level political support and helps ensure that it 
has regional ownership and is sustainable. 
A country-specific FETPV has been 
established in China. After joining the regional 
FETPV in 2009, China adopted the principle 
of learning by providing services and applied 
a similar approach to establish a national-level 
FETPV, which was launched in November 
2010. The two-year programme, comprising a 
series of workshops and field-based training 
courses, has so far trained three cohorts of a 
total of 53 veterinarians from provinces and 
municipalities. The growing China-FETPV 
network has become a significant national 
platform for emergency response and animal 
health activities in China. The programme 
has provided government agencies with field 
veterinary epidemiologists who can respond 
effectively and rapidly to animal disease 
events. For instance, China-FETPV trainees 
played significant roles during recent national 
responses to outbreaks of avian influenza 
A(H7N9) and peste des petits ruminants 
(PPR), and recommendations from their 
investigations have influenced government 
policies on these diseases. The China-FETPV 
One of the most 
difficult challenges in 
developing this applied 
epidemiology training 
programme was in 
building institutional 
safeguard to enable 
trained individuals to 
apply their skills when 
they return to their 
workplaces 
FETPV trainees design and deliver questionnaires in order to assess risk factors for disease occurrence
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with 11 Asian countries in Thailand in 
December 2011. Workshop participants then 
applied them to their own laboratory needs. 
IMPLEMENTATION OF A LIMS 
FOR AFRICA
The Sistema Informativo dei Laboratori 
(SILAB – Information System for 
Laboratories) for Africa (SILABFA) is 
an Italian-designed LIMS that has been 
implemented in several African national 
veterinary laboratories since 2010 (Box 1). 
The system was developed by the Istituto 
Zooprofilattico Sperimentale dell’Abruzzo 
e del Molise Giuseppe Caporale (IZSAM 
– Experimental Institute for the Prevention of 
Animal Diseases of the Abruzzi and Molise 
Giuseppe Caporale), Teramo, Italy under a 
bilateral cooperation programme between 
their partners assess their requirements for 
an LIMS and select a system that matches 
their data needs and workflows. This tool 
provides a structured approach to defining 
requirements specific to each laboratory 
in major categories such as the operating 
system; case, sample and test management; 
and laboratory workflow. The resulting list 
of requirements can then be used to assess 
candidate LIMS and compare the offers of 
different vendors. FAO has also developed 
a roadmap for LIMS implementation (Figure 
1), which serves as a guide to the necessary 
steps and phases for implementing a 
successful and fit-for-purpose LIMS. These 
products were introduced to participants at 
an FAO workshop on “Laboratory Information 
Management Systems: Identifying Needs, 
Resources, and Ways Forward” conducted 
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A laboratory information 
management system for Africa
ADVANCES
Contributors: Gwenaelle Dauphin,1  Béatrice Mouillé, 1  Badi Besbes,1  Patrizia Colangeli,2  Ercole Del Negro2 
The control of most animal diseases relies on rapid, accurate and reliable laboratory diagnosis, among other 
factors. The efficiency of work processes in 
the laboratory, and therefore the speed and 
reliability of testing, can be greatly enhanced 
through the use of an electronic laboratory 
information management system (LIMS). Such 
software facilitates the tracking of samples 
from the collection point through testing and 
any advanced investigations to reporting, and 
maintains historical data. It also reduces the 
potential for manual errors downstream of 
initial data entry. In addition, the accreditation 
of a laboratory to International Organization 
of Standardization (ISO)/International 
Electrotechnical Commission (IEC) Standard 
17025 to support international trade requires 
an efficient LIMS. By standardizing laboratory 
diagnostic processes and sample tracking, 
an electronic LIMS is therefore an excellent 
tool for managing quality assurance and 
quality control and can also facilitate the 
laboratory accreditation process. The use of 
an LIMS can also facilitate the exchange and 
monitoring of information among laboratories 
within a country or region and between 
laboratories and their disease response 
partners. 
FAO TOOLS FOR LIMS 
SELECTION AND 
IMPLEMENTATION
An LIMS is a significant long-term investment 
that will have an impact on the vitality of the 
laboratory for many years after its installation. 
The process for selecting an LIMS should 
therefore be rigorous and based on a 
strong commitment to achieving the optimal 
outcome. 
Given the multiple benefits of LIMS, FAO 
has developed an LIMS assessment tool 
(available on request) to help laboratories and 
1 Food and Agriculture Organization of the United 
Nations (FAO)
2 Istituto Zooprofilatico Sperimentale dell’Abruzzo e 
del Molise Giussepe Caporale (IZSAM)
Since 2010, SILABFA has been implemented in the national veterinary laboratories of 
Botswana, Namibia, the United Republic of Tanzania, Zambia and Zimbabwe. Ethiopia, 
Tunisia and Uganda have officially requested its installation in their national veterinary 
laboratories. 
FAO has provided support through the following activities:
• SILABFA was installed in all sections of the Botswana National Veterinary Laboratory 
(BNVL) in 2012 and was linked to Botswana’s Livestock identification and traceability 
systems (LITS) in 2014, so that data inserted into one system are also automatically 
available in the other system. 
• SILABFA was installed in the central Tanzania Veterinary Laboratory Agency (TVLA) in 
2013 (Box 3) and connected to two of its six zonal offices (provincial laboratories). 
• A mission to assess the feasibility of implementing SILABFA in Uganda was conducted 
in 2014 using the FAO LIMS assessment tool in collaboration with the National Animal 
Disease Diagnostics and Epidemiology Centre (NADDEC). The potential for linking 
SILABFA and FAO’s EMPRES Global Animal Disease Information System (EMPRES-i) 
Event Mobile Application (EMA), implemented in Uganda since 2013,1 is being 
assessed. Such a linkage would allow more rapid identification and notification of 
outbreaks.
1 http://www.fao.org/in-action/new-mobile-application-proves-essential-to-uganda-veterinarians/en/
Box 1: SILAB for Africa 
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Italy and Namibia and is a Web-based 
system based on SILAB, which IZSAM 
uses for its own laboratory management 
requirements. In November 2011, the 
Southern African Development Community 
(SADC) recognized the benefits of SILABFA 
and recommended its adoption by national 
laboratories in the SADC region.3 Regional 
interest in the system has continued to grow, 
with other African countries requesting the 
installation of SILABFA, becoming actively 
involved in the project and even investing 
their own resources in it. Box 2 describes 
the steps towards SILABFA installation and 
implementation. Given the good feedback 
from pilot countries, the interest expressed 
by several other countries and the strong 
partnerships established between IZSAM 
and African laboratories, FAO has supported 
the establishment of SILABFA in additional 
countries (Box 1). This support aims to 
strengthen the overall management and 
quality of laboratory information at both the 
national and regional levels. Since 2012, 
IZSAM has used the FAO LIMS assessment 
tool in all its assessment missions prior to 
SILAB installation. 
1.  Official request by a country. 
2.  Laboratory pre-audit, using the FAO 
LIMS assessment tool.
3.  Project and agreement signed with 
the country. 
4.  Installation of server and local area 
network (LAN) in the laboratory. 
5.  Installation in pilot section(s) of the 
laboratory. 
6.  Training of local administrators, 
receptionists, technicians, etc. 
7. Customization of the LIMS to 
laboratory needs and specificities. 
8.  Expansion to other laboratory 
sections and/or zonal offices.
9.  Provision of a help-desk service from 
Italy via remote access to the African 
laboratory’s server. 
10.  Annual audits/follow-up visits. 
Box 2: Ten steps to SILABFA 
implementation 
SILABFA in the United Republic of Tanzania
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3 http://www.fao.org/ag/againfo/programmes/
en/empres/documents/docs/SADC_2011_
Recommendations.pdf
Figure 1: Roadmap to LIMS implementation
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An LIMS is part of the continuum of animal 
health data systems; it provides a bridge 
between field data and epidemiological 
analysis. With a well-functioning LIMS, national 
veterinary diagnostic laboratory activities will 
be better integrated with epidemiological 
surveillance systems. The implementation of a 
common LIMS in several countries of a region 
harmonizes and optimizes the development 
and implementation of individual LIMS, and 
can facilitate integrated animal disease control 
at the regional level, in line with the Regional 
Laboratory Network approach that FAO has 
been supporting in Africa.4  360
Since 2013, SILABFA has been successfully implemented at the Tanzania Veterinary 
Laboratory Agency (TVLA) in four pilot units: Sample Reception; Pathology; Bacteriology; 
and Animal Science. A dedicated server for SILABFA has been installed in a safe room, with 
an information technology expert provided by the Veterinary Services assisted by a specially 
trained staff member from TVLA. A SILABFA administrator has been appointed and all staff 
in the pilot units have been trained to use SILABFA. A remote connection from Italy to TVLA 
provides a daily help-desk service and responds to requests for customization to TVLA’s 
settings. TVLA staff have extended the system to all other laboratory sections of TVLA in 
Dar es Salaam. The previous, paper-based system has now been almost totally replaced 
(being used only during power outages), and all TVLA units use SILABFA for their day-to-
day work. 
SILABFA has also been implemented in two TVLA zonal offices (Arusha and Iringa). In 
January 2014, TVLA signed an agreement with an Internet service provider on making 
SILABFA accessible via the Internet as well as through the internal LAN. This new feature 
makes SILABFA available to the zonal offices through a direct connection to the TVLA 
headquarters server, without requiring local installation. These developments have facilitated 
the transmission of information on samples from the provincial to the central level. Future 
developments will include the installation of SILABFA in the other four zonal offices (Dodoma, 
Mwanza, Tabora and Mtwara). 
The linkage of SILABFA to the Tanzania Livestock Identification and Traceability System 
(TANLITS),1 which was developed with FAO support, has been discussed and agreement 
reached on retrieving data from the TANLITS database, which includes information on 
establishments (farms, villages, livestock markets, slaughterhouses) and animals of three 
species: cattle, sheep and goats. These data provide information on livestock identification 
and registration – farm and location, owner/keeper and address, animal breed and sex, etc.; 
animal movements – farm of origin, farm of destination, animals involved, date of movement, 
reason for movement, etc.; and animal health events – treatment, vaccination, test results, 
etc. TANLITS includes a Geographic Information System (GIS) application that visualizes the 
locations of establishments and the movements of animals, which will help to define zones or 
enforce bans on animal movements in disease outbreaks. To connect TANLITS to SILABFA, 
the database codes of SILABFA will be realigned with those of TANLITS, so that each animal 
sample and establishment of origin has one code in both databases.
1  http://www.animaltraceabilitysolutions.net/-/tanzania-established-the-national-animal-identification-and-
traceability-tanlits-by-using-the-ats-platform-
Box 3: Benefits of LIMS in a laboratory in the United Republic of Tanzania
SILABFA is innovative because it has 
been adapted to African veterinary laboratory 
settings; can be customized to individual 
laboratories; and – in many aspects – can be 
managed directly by an internal administrator 
(without specific expertise in information 
technology), using a specially designed form 
to collect any additional information required 
for epidemiological reasons. SILABFA is 
compliant with ISO/IEC Standard 17025 
and allows for faster turn-around times, 
automation, increased productivity, and 
stricter quality control of data and electronic 
reporting, with final test reports produced 
automatically and printed or sent directly by 
e-mail. The standardization and harmonization 
of the database language, which uses 
uniform names, codes and metadata for each 
entity (species, materials, tests, etc.), fosters 
data consistency and can facilitate the linking 
of SILABFA to other databases.
INTEGRATION WITH NATIONAL 
DATABASES
SILAB is easy to customize and can be 
connected to external databases such 
as national tracking systems or mobile 
applications. It has been linked to the 
livestock identification and traceability 
systems (LITS) in Botswana since 2014 (Box 
1) and in Namibia since the end of 2015, 
and the potential for doing so in the United 
Republic of Tanzania has been examined 
(Box 3). Connecting SILABFA to an LITS 
can improve animal health surveillance and 
certification and enhance export procedures 
for livestock and livestock products. 
4 http://www.fao.org/ag/againfo/programmes/en/empres/news_260914b.html;  
http://www.fao.org/ag/againfo/programmes/en/empres/news_201213b.html
Figure 2: Screen shot from SILABFA
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In recent years, following outbreaks of infectious diseases that include severe acute respiratory syndrome 
(SARS), pandemic influenza H5N1, dengue 
haemorrhagic fever, Middle Eastern respiratory 
syndrome (MERS), Chikungunya, Zika and 
Ebola viruses' the global community has 
become increasingly aware of the threat of 
emergence or re-emergence of diseases at 
the human/livestock/wildlife and environment 
interface. It is estimated that about 60 percent 
of known human infectious diseases originate 
from animals, while 75 percent of emerging 
human pathogens are zoonotic, with most 
coming from wildlife (Jones et al., 2008; Taylor, 
Latham and Woolhouse, 2001; WHO, 2007). 
The fact that more than 70 percent  of new 
and emerging diseases originate in animals 
calls for a deeper level of cooperation between 
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the animal and human health sectors at the 
national and international levels (WHO, 2007).
In Southern Africa, humans and animals 
have increasingly been competing for limited 
habitats. Human encroachment into virgin 
territories not only introduces more vectors 
and reservoirs of infection to new hosts, 
but also leads to human/livestock/wildlife 
conflicts at this highly mobile interface. Animal 
populations are being pushed into constricted 
areas, creating geographic zonation that 
is detrimental to wildlife populations, and 
altering the structure of animal communities 
(Patz et al., 2004; Williamson and Williamson, 
1981; Taylor and Martin, 1987; Harris et al., 
2009; Ferguson and Hanks 2010; 2012; 
Gadd, 2011; Scoones et al., 2010; Cozzi et 
al. 2013), disrupting natural migratory paths in 
the process.  
The formation of transfrontier conservation 
areas (TFCAs) or “Peace Parks” ensures 
joint cross-border management of natural 
resources among neighbouring countries, 
while facilitating movement of people and 
wildlife within a mosaic of protected areas, 
rural and urban development, subsistence 
agriculture, and regional infrastructural 
and economic development, enhancing 
livelihoods and conserving Africa’s wildlife 
heritage and natural resources. Zimbabwe 
hosts parts of five main TFCAs: Lower 
Zambezi–Mana Pools, Mapungubwe–
Limpopo/Shashe, Chimanimani, Great 
Limpopo and Kavango-Zambezi. Disease 
surveillance studies at the livestock/wildlife/
human interface have been carried out where 
the Great Limpopo (GL) TFCA straddles the 
borders of Mozambique (Limpopo National 
Driving giraffes with a helicopter
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2015 and eventually came to an end 
in January 2016, was thought to have 
been caused by cattle/buffalo contact in 
Masvingo Province in GL-TFCA. Other 
studies have confirmed the presence 
of RVF, brucellosis and theileriosis in 
buffaloes (Caron et al., 2013). A review 
of the epidemiology and control of rabies 
in Zimbabwe concluded that rabies virus 
isolates from domestic and wild canids, 
such as jackals, are phylogenetically 
similar and capable of crossing species 
(Sabeta, Bingham and Nel, 2002). These 
studies confirm the presence of important 
transboundary and zoonotic diseases 
at the livestock/wildlife/human interface 
in Zimbabwe’s major TFCAs and NPs, 
presenting a high risk of infection in both 
animals and humans.
Integrated small-scale farming and 
livestock systems are the main sources 
of subsistence and cash income for an 
estimated 80 percent of rural communities in 
Zimbabwe according to:
• the 2016 National Budget Statement 
“Building a Conducive Environment that 
Attracts Foreign Direct Investment”; 
• the Poverty, Income, Consumption 
and Expenditure Survey (PICES) 
2011/2012 report;
• the Zimbabwe Vulnerability Assessment 
Committee (ZimVAC) 2015 report; 
animals, humans and the environment.  Lumpy 
skin disease (LSD) and zoonoses such 
as rabies, brucellosis, bovine tuberculosis 
(bTB), Rift Valley fever and anthrax have been 
confirmed in both wildlife and livestock for 
many years in Zimbabwe (Caron et al., 2013). 
FMD, bTB and theileriosis are known to 
be shared between domestic cattle (Bos 
taurus/B. indicus) and the African buffalo 
(Syncerus caffer). African buffaloes that are 
sero-positive to bTB have been identified in 
GL-TFCA (Masterson et al., 2014). The free 
movement of buffaloes from northern Kruger 
in South Africa into the Zimbabwean portion 
of GL-TFCA is of major concern regarding not 
only the potential of spread of bTB to buffalo 
herds within Gonarezhou NP, but also the 
impact of the disease on a relatively small and 
unstable predator population. It is important 
to note that while an intact, hard-edge 
fence barrier separates buffaloes in Kruger 
National Park from cattle on the South African 
side of the Limpopo, the situation on the 
Zimbabwean side of the river is characterized 
by a far more intimate interface and 
intermingling between cattle and buffaloes, 
which poses a serious threat of transmission 
of the disease to communal cattle herds, with 
subsequent entry into the human food chain 
(Masterson et al., 2014).
The most recent FMD outbreak, 
which occurred in Zimbabwe in April 
Park), South Africa (Kruger National Park) 
and Zimbabwe (Gonarezhou National Park), 
joining together some of the most carefully 
preserved wildlife areas in southern Africa 
into a vast conservation zone of 37 572 km² 
(about the size of the Netherlands) that has 
one of the world’s richest concentrations of 
wildlife. 
In addition to hosting parts of southern 
Africa’s major TFCAs, Zimbabwe has 
national parks (NPs) and national wildlife 
protected areas (NWPAs) at Hwange, 
Gonarezhou, Chirisa, Chizarira, Mana 
Pools, Matusadona, Mavuradonha and the 
Save Valley Conservancy, where livestock, 
wildlife and humans coexist, sharing natural 
resources such as land, food and water. 
While these large tracts of land earmarked 
for mixed conservation and development have 
enormous potential in connecting wildlife 
populations and enhancing the integrity and 
viability of protected areas, they also create 
substantial intersectoral challenges, with 
transboundary diseases causing potential 
flashpoints (Bengis, 2005; DeGarine-
Wichatitsky et al., 2012). Many of these 
multiple-use areas straddle international 
borders, often in regions of high FMD 
endemism. Various animal and human disease 
pathogens and vectors such as ticks, tsetse 
flies and mosquitoes commonly circulate 
at the interface between wildlife, domestic 
Restraining an impala
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zoonoses – including bTB, rabies, anthrax, 
RVF, brucellosis and helminthiases – through 
improved livestock husbandry, personal 
hygiene and disease prevention skills based 
on the “One Health” approach. This training 
will enrich their understanding of the aims of 
animal health programmes and the principles 
that are applied.
Ticks are important vectors for animal 
and zoonotic diseases such as ehrlichiosis, 
anaplasmosis and tick bite fever caused by 
Rickettsia africae species in southern Africa. 
Under the FAO and EU projects, ticks will be 
collected from cattle and small ruminants at 
selected communal dip tanks for enumeration, 
identification and testing for pathogen 
carriage. In wildlife areas, the dragging 
technique will be used to sample ticks from 
grass, and blood and tissue samples will 
be collected from selected wildlife animal 
species such as lions, buffaloes and other 
wild ungulates. Up to 40 African buffaloes will 
be darted from a helicopter and immobilized 
with highly potent narcotics. Opioids such 
as etorphine (an immobilizing drug) and 
azaperone (a tranquillizer) will be used to 
start with. For animals that appear too deeply 
sedated or that have severe respiratory 
depression, butorphanol may be administered 
intravenously as a partial opioid antagonist 
(reversal drug). After sampling, the opioid 
antagonist Diprenorphine (M5050) will be 
injected into a vein in the animal’s ear (De 
Garine-Wichatitsky et al., 2010; Masterson 
et al., 2014). Drugs, rifles and helicopter 
services will be procured through the FAO 
project for use by trained wildlife veterinarians 
and hunters, including FAO veterinarians and 
wildlife experts at the FAO country office and 
Subregional Office for Southern Africa.
Control of TADs and zoonoses at the 
wildlife/livestock interface in the area bordering 
the two districts of Nkayi and Lupane and 
adjacent communities will ensure improved 
and sustainable livestock production and 
productivity, resulting in increased household 
income and better livelihoods. Livestock 
keeping is critical for small-scale farmers living 
in and adjacent to TFCAs in southern Africa, 
not only from a socio-economic point of view 
but also from a public health perspective. 
In these communities, HIV prevalence 
is often high, and consequences of the 
immunosupression of human populations – 
such as higher susceptibility to zoonoses – are 
likely (Giller et al., 2012; Lloyd-Smith, Poss 
and Grenfell, 2008). In addition, poor and/or 
difficult access to health facilities increases 
the impact of diseases in human populations. 
The presence of RVF and brucellosis in cattle 
and the risk of spillover of bTB to cattle from 
buffaloes increase the risk of transmission to 
humans. A holistic approach to animal and 
public health surveillance and control at the 
wildlife/livestock/human interface will be an 
(TCP/ZIM/3502) and a livestock project 
that is funded by the European Union (EU) 
(GCP/ZIM/022/EC) and being implemented 
in the two districts of Nkayi and Lupane in 
Matabeleland, North Province. A survey will 
be conducted to assess the prevalence of 
economically important TADs, and geomatic 
information tools will be used to develop 
a disease distribution atlas for Chirisa and 
Chizarira NWPAs and Hwange NP, which 
are adjacent to the two project districts. 
The disease maps and atlas that are being 
produced will document the distribution 
patterns of important vectors and disease 
pathogens. Once completed, the atlas will be 
a tool for animal health workers and wildlife 
management staff to support the prevention, 
identification, reporting and management 
of critical animal diseases of economic and 
zoonotic importance. 
The two projects also aim to train hunters 
and NP personnel in disease surveillance, 
safe wildlife capture techniques and 
sampling. Farmers living adjacent to the 
wildlife protection areas will receive training 
on disease recognition and participatory 
surveillance, and animal health workers will 
receive training in pen-side disease screening, 
sampling, sample packaging and preservation. 
The Central Veterinary Laboratory (CVL) 
will benefit from enhanced testing and 
diagnostic capacities in the form of laboratory 
equipment and reagents for carrying out 
laboratory screening and confirmation of 
the diseases, including the IFN-γ (gamma 
interferon) enzyme-linked immunosorbent 
assay (ELISA) test for bTB. The laboratory will 
also be equipped to undertake microscopic 
examination of blood and blood parasites, 
particularly Theileria species. Human health 
workers will receive targeted training in 
the management and prevention of critical 
• the Zimbabwe Agenda for Sustainable 
Socio-Economic Transformation (Zim. 
Asset) 2013—2018;
• the Comprehensive Africa Agriculture 
Development. Programme (CAADP) 
Zimbabwe Agriculture Investment Plan 
(ZAIP); 
• the 11th National Indicative Programme 
2014– 2020 of the European 
Development Fund;
• the Zimbabwe Country Programme 
Framework 2016–2020;
• the Zimbabwe United Nations 
Development Assistance Framework 
(ZUNDAF) 2016–2020.
The research studies into TADs and 
zoonotic diseases previously mentioned have 
found that small-scale livestock enterprises 
are at higher risk of infection with, and 
spread of, these diseases, with serious 
consequences for livestock production and 
productivity and for human health (Caron 
et al., 2013; 2016). For instance, bTB is a 
controlled animal disease that can be carried 
and transmitted by an array of mammalian 
species but for which cattle and buffalo are 
the most important reservoirs in southern 
Africa. Being closely related to human 
tuberculosis, bTB is not only transmissible 
to humans, but also has similar disease 
progression and outcomes in humans 
and animals. bTB is therefore a significant 
zoonosis in pastoral communities with 
high prevalence rates of HIV infection and 
malnutrition, two important epidemiological 
risk factors for humans in the NPs and GL-
TFCA (Masterson et al., 2014).The Zimbabwe 
country office of the Food and Agriculture 
Organization of the United Nations (FAO) is 
currently supporting a study under an FAO 
Technical Cooperation Programme project 
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essential factor for the success of protected 
areas in southern Africa. Capacity building 
for farmers and staff from the veterinary 
services, the Ministry of Health and NPs will 
lead to better human and livestock health 
and improved veterinary and medical service 
delivery. 
The advent of integrated multiple land-use 
policies encapsulated by the strategic vision 
of “transfrontier conservation” within a One 
Health framework (Hanks, 2003; Osofsky, 
Cumming and Kock, 2008) represents a 
major paradigm shift and step forward in 
African conservation. 360
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to August 2013 (OIE data, 2013).2 In 
these outbreaks, the implementation of 
specific mitigation measures such as LSD 
vaccination, strict movement restrictions and 
quarantine successfully controlled the disease 
(Brenner et al., 2006: N. Galon, personal 
communication). The Islamic Republic of 
Iran and the Russian Federation reported the 
disease for the first time in 2014 and 2015 
respectively, and Turkey and Azerbaijan have 
consistently been reporting new cases since 
2013. A recent publication indicated that LSD 
was recognized in Iraq in August 2013 (Al-
Salihi and Hassan, 2015).
The disease spreads rapidly in areas of 
high cattle density. For instance, after Cyprus 
reported the first six outbreaks in November–
December 2014 in the northeastern 
peninsula, the disease was soon detected 
approximately 47–52 km from the original 
location despite animal movement controls. 
Results of epidemiological investigation were 
inconclusive and could not rule out disease 
spread through unauthorized movements of 
infected cattle.The first incursion of LSD in 
the European part of Turkey was reported 
in May 2015. Between May and  November 
2015, a total of 17 outbreaks were notified in 
European Turkey. Vaccination of susceptible 
animals and culling of affected animals were 
implemented as control measures. Further 
outbreaks were reported in beef cattle farms 
in the adjacent Greek region of Evros in 
August 2015. By the end of 2015, a total of 
117 LSD outbreaks were notified in Greece, 
affecting seven regions: Evros, Xanthi, 
Rodopi, Chalkidiki, Thessaloniki, Kavala and 
Limnos island. Stamping out, movement 
restrictions for live bovines and bovine 
products and emergency vaccination in the 
affected regions were implemented. 
In September 2015, LSD was reported 
in the Russian Federation, in Dagestan, 
financial costs related to infected herds 
were US$5–8 per head of local zebu and 
US$42–73 per head of Holstein Friesian 
cattle. The disease can lead to restrictions 
or total bans in the international trade of 
live animals and animal products (Gari et 
al., 2011). The incidence of LSD is higher 
during wet seasons when populations of 
flies are more abundant (Gari et al., 2010; 
2011; 2012). In this regard, LSD has been 
found to be more prevalent in low-lying 
areas and along watercourses.
LSD was historically endemic in many 
African countries, but it has now spread 
throughout the Near East and, more recently, 
into Asia and Europe (OIE, 2015a). LSD 
was detected in Egypt for the first time in 
1988, and subsequently became enzootic 
(Ali et al., 1990; House et al., 1990). In 
1989, the disease spread from Egypt to 
Israel via insects (Davies, 1991). A second 
outbreak in Israel  was reported in 2006 
(Brenner et al., 2006). Israel experienced 
213 outbreaks of LSD from July 2012 
Lumpy skin disease (LSD) is caused by the LSD virus (genus Capripoxvirus, family Poxviridae) and affects mainly 
cattle and Asian water buffaloes. LSD 
is transmitted primarily by mechanical 
vectors (Stomoxys spp., biting flies). Direct 
transmission can also occur between 
infected animals, but such transmission is 
rare and of low epidemiological significance. 
The disease usually moves from infected to 
uninfected areas through the transport of 
infected animals, and sometimes through 
the introduction of infected vectors. Poorly 
regulated movements of large numbers of 
animals, often associated with festivities, 
represent a risk for introduction of the 
disease. Outbreaks of LSD require immediate 
notification under the Terrestrial Animal Health 
Code of the World Organisation for Animal 
Health (OIE, 2015b).
LSD is a characterized by substantial 
economic losses in dairy and meat 
production and damage to hides. A 
recent study in Ethiopia estimated that the 
©
FA
O
/A
m
i V
ita
le
Emergence of lumpy skin disease 
in Asia and Europe
IN ACTION 
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Eran Raizman1 
Figure 1: LSD outbreak distribution in Europe, Caucasus and the Near East (as of 18 September 2016)
1 Food and Agriculture Organization of the United 
Nations (FAO)
2 http://www.oie.int/wahis_2/public/wahid.php/
Reviewreport/Review/viewsummary?reportid=12157
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CONTROL AND PREVENTION 
OF LSD
LSD can be prevented by implementing 
biosecurity measures at the farm level and 
imposing restrictions on the movement of 
susceptible animals and commodities from 
infected areas. In endemic areas control is 
confined to vaccination.
Policies for controlling and eradicating 
LSD in cases of incursion include stamping 
out and a combination of the following 
strategies (Coetzer and Tuppurainen, 2014): 
• sanitary disposal of destroyed animals 
and contaminated animal products, to 
remove the source of infection; 
• quarantine and movement controls of 
animals, products and other potentially 
infected items, to prevent spread of 
infection; 
• decontamination of facilities, equipment 
and other items, to remove fomites 
and minimize spread of the virus from 
infected animals and premises; 
• control of insect vectors in the initial 
stages of an outbreak; 
• tracing and surveillance to determine the 
source and extent of infection and provide 
proof of freedom from the disease; 
• zoning and/or compartmentalization 
to define infected and disease-free 
premises and areas; 
• awareness campaigns to facilitate 
cooperation from industry and the 
community; 
• ring vaccination, as part of a modified 
stamping-out policy.
VACCINES
Currently available vaccines against LSD 
include:
• Lumpy Skin Disease Vaccine – 
Onderstepoort Biological Products, 
South Africa (LSD virus [LSDV] 
Neethling strain);
a second rise in body temperature, four to 
ten days after the initial febrile response. 
Nodules involve the skin, subcutaneous tissue 
and often the underlying muscle. The size of 
the nodules is generally uniform, although 
several nodules may fuse to form a larger 
one. Nodules are firm, round and raised. In 
cattle, the nodules are often recognized only 
when the skin is palpated or moistened, and 
in most cases they are particularly noticeable 
in the perineum and on the vulva. Acute and 
subacute nodules are reddish-grey while 
the dermis and subcutaneous tissue show 
oedema. Nodular lesions may extend into 
the tendons, resulting in lameness. Skin 
lesions resolve and become indurated or 
sequestrated, leaving deep ulcers partly 
filled with granulation tissue, which often 
suppurates.
Clinical signs of LSD may include:
• dissemination of small bumps (nodules) 
under the skin in the nose and mouth 
and on the body;
• enlarged superficial lymph nodes; 
• swollen and tender udder or testicles;
• discharge from the eyes and nose;
• bulls becoming sterile and cows having 
abortions.
DEFINITIVE DIAGNOSIS 
Initial diagnosis can be made in the presence 
of typical lesions on the skin and in the 
mouths of infected animals. However, as 
other diseases present in similar forms 
in cattle, but require different methods of 
control and treatment from those for LSD, a 
definitive diagnosis can only be confirmed 
by submitting appropriate samples of skin 
lesions to a laboratory where the virus can be 
identified. Molecular diagnostic tests such as 
conventional and real-time polymerase chain 
reaction (PCR) assays are rapid and highly 
sensitive, and are widely used in veterinary 
diagnostic laboratories. 
Chechnya and North Ossetia. By July 2016, 
it had spread to Stavropol, Astrakhan, 
Krasnodar and Kalmyk regions, resulting in 
155 outbreaks.
In April 2016, LSD was reported in 
Greece in Serres, the region that was not 
affected and not covered by vaccination 
in 2015. In total 69 new outbreaks were 
confirmed between April to the beginning 
of July 2016 in Greece, in Serres, Pella, 
Imathia, Drama, Kilkis, Lesbos, Thessaloniki 
and Kavala regions. During this period, two 
outbreaks were reported in Edirne, Turkey.
In April 2016, the first LSD incursion was 
registered in Bulgaria, in Haskovo region, 
approximately 60 km from the borders with 
Greece and Turkey, followed by outbreaks 
in southwest regions; in June 2016, two 
northern regions were affected. By the end 
of June, LSD affected 17 regions in Bulgaria, 
with 201 outbreaks. A total stamping out 
policy and movement restrictions were 
applied. Emergency vaccination started in 
affected villages and in the 20-km protection 
zones around the outbreaks. This was later 
extended to blanket vaccination across the 
whole country. 
In April 2016, LSD was registered in The 
former Yugoslav Republic of Macedonia, and by 
June, 387 outbreaks were confirmed. Modified 
stamping out, movement restrictions and 
vaccination were implemented. By July 2016, 
198 and 53 outbreaks were also confirmed in 
Serbia and in Montenegro respectively, and 1 
each in Albania and Kazakhstan.
TRANSMISSION
The main pathways for transmission are 
biting and blood-feeding arthropods, 
including mosquitoes and flies (Gari et al., 
2010). Disease incidence is highest in wet/
warm weather. In some areas, decreases in 
incidence during periods of low rainfall are 
possibly linked to declines in insect vector 
occurrence/numbers. 
Although rare, transmission also occurs 
through direct contact, and the disease can 
also spread from contaminated feed and 
water. In the 2013 outbreak in Israel, the virus 
was isolated from the saliva of cattle, but the 
epidemiologic importance of this possible 
transmission route is yet to be elucidated. The 
virus can remain active in skin scabs and dry 
hides for up to six months if they are kept in 
the dark. Nevertheless, in some outbreaks the 
routes of transmission remain unclear. 
CLINICAL SIGNS 
The morbidity rate of LSD is between 5 and 
45 percent on affected farms. The mortality 
rate may be as high as 10 percent, even 
among indigenous cattle. Typically, cattle 
develop a biphasic febrile response two 
to four weeks after exposure to the virus. 
Characteristic skin nodules appear during 
Figure 2: LSD outbreak distribution in Europe, Caucasus and the Near East (as of 18 September 2016)
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mind that the quality of vaccines varies, 
and live virus vaccine is of low stability in 
sunlight. SPPV and goat pox virus vaccines 
can be used at coverage levels of 80–90 
percent (FAO, 2015). A recent study in Israel 
compared the Neethling strain vaccine to the 
Jovac SPPV vaccine at ten times the sheep 
dose. While the efficacy of the Neethling 
strain vaccine was statistically significantly 
higher than that of the SPPV vaccine, both 
vaccines were shown to protect against 
natural exposure to LSDV during outbreaks 
(Ben Gera et al., 2015). 360
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composed of three CVOs – from Ethiopia (as 
chair), Burundi and Uganda – the Coordinator 
of the CVO Network, the coordinators of 
the Eastern Africa Region Epidemiology 
Network (EAREN) and the Eastern Africa 
Region Laboratory Network (EARLN) and 
representatives of IGAD, the East African 
Community (EAC), AU-IBAR and the AU’s 
Pan African Veterinary Vaccine Centre (AU-
PANVAC). 
The main recommendations adopted by 
participants included the following:
• Countries should take the necessary 
actions to: i) conduct/update national 
censuses of small ruminant populations; 
ii) ensure that their national strategies are 
consistent and aligned with the GCES, 
as the reference document; iii) ensure 
that only quality vaccines certified by 
AU-PANVAC are used; iv) assess the 
effectiveness of vaccinations through post-
PPR ROADMAP MEETING FOR 
EASTERN AFRICA
The first PPR roadmap meeting for the 
Eastern African region after adoption of the 
GCES was held from 10 to 11 September 
2015 in Kampala, Uganda as the second in 
the series of regional PPR roadmap meetings 
planned for 2015 and 2016 (Table 1). 
Mr Alhaji Jallow, FAO Representative 
in Uganda, opened the meeting, which 
was attended by chief veterinary officers 
(CVOs), laboratory representatives and 
epidemiologists from 11 countries – 
Burundi, the Democratic Republic of the 
Congo, Djibouti, Eritrea, Ethiopia, Kenya, 
Somalia, South Sudan, the Sudan, Uganda 
and the United Republic of Tanzania – 
and representatives from OIE and FAO. 
After presentation of the GCES8 and the 
recommendations of the Abidjan conference,9 
meeting participants assessed the PPR 
situation and the response capacity of the 
national veterinary services of countries in 
the region, identified other small ruminant 
diseases that could be controlled alongside 
PPR, and formulated a regional roadmap 
for Eastern Africa outlining a coordinated 
approach for the control and eradication 
of PPR throughout the region. It was 
necessary to obtain countries’ commitment to 
implementing this regional roadmap.
The two main outputs of the meeting were: 
i) adoption of the PPR Stage Progression 
2015–2030 as the starting point for the 
step-wise GCES approach (Figure 2); and 
ii) establishment of a regional advisory group 
The Global Strategy for the Control and Eradication of PPR (also known as the Global Control and 
Eradication Strategy – GCES) of FAO and 
the World Organisation for Animal Health 
(OIE) was endorsed at the International 
Conference for the Control and Eradication 
of Peste des Petits Ruminants (PPR) held 
in Abidjan, Côte d’Ivoire from 31 March to 2 
April 2015. The conference recommended 
that meetings on regional roadmaps be 
held to ensure the continuous evaluation 
and monitoring of the PPR situation. 
Regional roadmap strategies and national 
strategic plans should be aligned with the 
global strategy and regional and national 
contexts. 
PPR is one of the most significant 
small ruminant diseases in the East African 
region (Figure 1). 
Several countries in East Africa have 
developed, or are developing, national PPR 
strategies, while the Intergovernmental 
Authority on Development (IGAD)3 and 
the African Union’s Interafrican Bureau 
for Animal Resources (AU-IBAR) have 
developed PPR strategies for Africa at the 
regional (IGAD) and continental (AU-IBAR) 
levels; all of these strategies need to be 
aligned with the GCES. There are also 
ongoing PPR control initiatives within the 
region, mainly supported by IGAD, AU-
IBAR and FAO. 
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Eastern Africa regional roadmap for 
the control and eradication of peste des 
petits ruminants: support from strong 
epidemiology and laboratory networks 
IN ACTION 
Contributors: Bouna Diop,1 Felix Njeumi 2
1 Food and Agriculture Organization of the United Nations 
(FAO), Emergency Centre for Transboundary Animal 
Disease Operations (ECTAD), Nairobi 
2 FAO Animal Production and Health Division, Rome
3 Member countries of IGAD are Djibouti, Eritrea, Ethiopia, 
Kenya, Somalia, South Sudan, the Sudan and Uganda.
4 Economic Community of West African States
5 South Asian Association for Regional Cooperation
6 Southern African Development Community
7 Association of Southeast Asian Nations
8 http://www.fao.org/3/a-i4460e
9 http://www.oie.int/for-the-media/press-releases/
detail/article/publication-of-the-abidjan-conference-
recommendations-adoption-of-the-global-strategy-for-
the-contr/
Figure 1: Known PPR outbreaks in the East 
African region with virus confirmation
Table 1: Schedule of regional PPR roadmap meetings
Region Date and location
Central Africa 24–25 August 2015, Yaoundé, Cameroon
Eastern Africa 10–11 September 2015, Kampala, Uganda
Middle East 3–5 December 2015, Doha, Qatar
Central Asia 23–25 February 2016, Almaty, Kazakhstan
SAARC2 11–12 April 2016, Nagarkot, Nepal
ECOWAS1 11–13 May 2016, Dakar, Senegal
SADC3 October 2016, to be decided
North Africa October 2016, Tunis, Tunisia
ASEAN4, China, Mongolia and Timor-Leste December 2016, to be decided
2010 – present
2000 – 2009
1990 – 1999
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take the necessary action to develop/update 
national RVF contingency plans, given the high 
chances of RVF occurrence in the near future, 
based on climate predictions. 
Other recommendations included 
strengthening existing sub-networks (for ASF 
and FMD) and establishing new ones (for 
rabies, contagious caprine pleuropneumonia 
and PPR) with the support of technical partners; 
addressing the weak disease reporting 
and information sharing among countries; 
requesting IGAD to prepare clear rules and 
principles to govern the management of 
networks established through a defined charter; 
requesting Ethiopia’s National Animal Health 
Diagnostic and Investigation Centre (NAHDIC), 
as the Regional Support Laboratory, to develop 
an action plan to guide its support to other 
countries; mapping all ongoing projects and 
programmes to avoid duplication; conducting 
antimicrobial resistance (AMR) surveillance 
activities along livestock value chains, and 
prioritizing the development of an AMR 
mitigation strategy; mapping and documentation 
of One Health activities in the region; and 
developing national policies, strategies and 
legislation to rationalize the provision of 
veterinary services by the public or private 
sectors or through public–private partnerships. 
Additional participants at the RAHN meeting 
included representatives from AU-IBAR, 
AU-PANVAC and OIE, and major project 
implementation partners, including partners 
of the United States Agency for International 
Development’s (USAID’s) Emerging Pandemic 
Threats 2 (EPT2) Program – PREDICT-2, the 
Preparedness & Response Project and the One 
Health Workforce; the United States Centers 
for Disease Control and Prevention (CDC); the 
International Livestock Research Institute (ILRI); 
and the Uganda Virus Research Institute (UVRI). 
FAO participants included the Emergency 
Prevention System (EMPRES, Rome, Italy), 
the Subregional Office for Eastern Africa (SFE, 
Addis Ababa, Ethiopia), FAO Representation 
in Kenya (Nairobi, Kenya) and the Emergency 
Centre for Transboundary Animal Disease 
Operations (ECTAD, Nairobi, Kenya). 360
a tool to help countries estimate the 
costs and economic impact of PPR 
vaccination, using the tool developed by 
FAO for highly pathogenic avian influenza 
as a model; and v) develop a summarized 
version of the GCES.
EASTERN AFRICA REGIONAL 
ANIMAL HEALTH NETWORKS 
MEETING
The annual meeting of the Eastern Africa 
Regional Animal Health Network (RAHN) was 
held on 7–9 September 2015, back-to-back 
with the PPR Roadmap Meeting for Eastern 
African. The network comprises CVOs, the 
national focal points of EAREN and EARLN, 
and the sub-network coordinators for foot-
and-mouth disease (FMD) and African swine 
fever (ASF). Its annual meeting serves as an 
important forum for discussion and information 
sharing on disease control in the region. Sixty-
eight participants from 11 countries attended 
to discuss regional needs and practicalities. 
The RAHN meeting prioritized four 
major diseases for regional attention – PPR, 
Rift Valley fever (RVF), FMD and ASF – 
and recommended that: i) IGAD take the 
necessary action to coordinate and anchor 
the RAHN, with support from EAC and FAO; 
ii) the ASF sub-network finalize the regional 
strategy by December 2015; iii) FAO, OIE, 
IGAD and EAC support the establishment 
of a PPR sub-network for Eastern Africa, as 
recommended by the GCES; and iv) countries 
vaccination evaluation; and vi) commit to 
adopting the PPR step-wise approach at 
the national level and to the subsequent 
PPR regional roadmap process.
• AU-IBAR, AU-PANVAC, IGAD 
and EAC should: i) ensure that the 
continental (AU-IBAR) and regional 
(IGAD) strategies are consistent and 
aligned with the GCES; ii) define their 
respective roles in implementation of 
the GCES; iii) establish a roster of 
regional experts to address countries’ 
needs in epidemiology and to explore 
the possibility of establishing a regional 
leading epidemiology centre; iv) map 
all existing (and planned) national and 
regional projects related to PPR control 
and eradication, and identify existing 
gaps; and v) form a joint Eastern Africa 
Coordination and Technical Committee 
between IGAD and EAC, to take 
advantage of the work initiated by IGAD.
• FAO and OIE, together with regional 
partners and countries, should: i) ensure 
that adequate financial resources are 
mobilized for implementing the GCES 
at the national, regional and international 
levels; ii) provide further guidance on 
the potential for combining vaccination 
protocols for PPR and other small 
ruminant diseases in the near future; iii) 
provide countries with the necessary 
training in post-vaccination evaluation; 
iv) explore the possibility of developing 
Participants at the Eastern Africa RAHN meeting
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Figure 2: Progressive step-wise approach for the prevention and control of PPR
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and to support investments in control 
programmes. 
The expert discussion 
recommended that a literature 
review be conducted to improve 
understanding of the most up to date 
economic analysis and methods in 
animal health and their application 
to FMD issues. The review showed 
that most economic analyses so 
far have been conducted using a 
cost–benefit analysis framework, 
and many have not taken into 
account the socio-economic impact 
and value of interventions and their 
adoption by farmers. Any FMD control 
strategy or eradication plan has to 
pay attention to the engagement 
of livestock owners, so studies are 
required to build understanding of the 
impacts on this stakeholder group 
of implementing and continuing 
the disease prevention or control 
strategy, i.e. of each stage of the PCP-FMD. 
Demonstrating the potential positive impact of 
an FMD control strategy is essential in helping 
decision-makers to determine the best way of 
allocating limited resources. 
The socio-economic guidelines discussed 
by the expert consultation will include sections 
on each PCP stage, and will describe the 
likely socio-economic issues to be taken into 
account in the design and implementation of 
national FMD control plans. At each stage, 
considerations for this socio-economic analysis 
include stakeholder identification, socio-
economic indicators and data requirements. 
Application of the socio-economic guidelines is 
expected to lead to more robust and sustainable 
national control plans that will expedite 
achievement of the objectives and milestones 
of the Global FMD Control Strategy. 360
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economic benefits that are greater or equal 
to the extra cost. However, while veterinary 
services are well positioned to demonstrate 
the technical and economic benefits of a 
disease intervention, they do not usually have 
the expertise to gather information or conduct 
analyses. 
In this context it is necessary for the PCP-
FMD approach to include consideration of the 
socio-economic impacts of both the disease 
and the control measures at each stage. 
Economic methods and analysis can be used 
to determine key policy requirements for moving 
from one PCP stage to the next. Guidelines 
are therefore required to assist countries 
in assessing the impact of the disease and 
obtaining economic data to support policy and 
the design of sustainable control programmes. 
For these reasons, in April 2015 an expert 
panel met in Rome to explore the development 
of guidelines for socio-economic assessments 
that assist countries in determining the impact, 
costs and benefits of interventions along 
the PCP-FMD pathway. The expert panel 
discussed the methods and tools available for 
conducting socio-economic analyses to provide 
evidence from different production systems 
The Progressive Control Pathway for Foot-and-Mouth Disease (PCP-FMD), 
promoted and launched by FAO 
and the World Organisation for 
Animal Health (OIE) in 2012, is 
a non-prescribed approach to 
the progressive control of FMD 
in endemic settings. It defines six 
stages in which the circulation of first 
clinical FMD and then FMD virus 
are progressively controlled and 
finally eradicated. In Stage 0, FMD 
is endemically present in a country, 
but there is no available information 
on its extent, impact and routes of 
transmission. In Stage 1, the focus 
is on developing an understanding of 
the endemic FMD virus strain(s), the 
routes of virus transmission and the 
livestock production systems in the 
country. In Stage 2, FMD control is 
implemented to reduce the impact 
of clinical FMD in the country or in a specific 
region or livestock sector in the country. In 
Stage 3, the control of FMD becomes more 
aggressive with the aim of eliminating FMD 
virus circulation and putting in place a rapid 
detection and response mechanism for all 
FMD outbreaks. In Stage 4, FMD outbreaks 
are limited to occasional incursions from 
neighbouring countries and every incursion is 
swiftly curtailed. Vaccination is usually still part 
of the FMD control plan, and the country can 
apply to OIE for official recognition of its status 
as FMD-free with vaccination as it moves into 
Stage 5, when the country prepares to phase 
out FMD vaccination and applies for an official 
OIE status of FMD-free without vaccination. 
Decisions related to animal disease 
control involve economic choices at several 
levels, and a range of alternative approaches 
need to be evaluated to demonstrate the 
full economic benefit of a control strategy. 
The proposed disease intervention should 
be socially acceptable and should deliver 
Expert panel meeting on developing socio-
economic guidelines for the Progressive 
Control Pathway for Foot-and-Mouth 
Disease, 13–15 May 2015, Rome
NEWS
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Figure 1: Stage progression in the Progressive Control Pathway
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Doctor Ali Gholam Kiani left us in December 2015. He left us 
silently, with discretion, coherently with how he was in life. A 
dear friend to all, he was also a dedicated professional and an 
ambassador of good will. 
Dr Kiani was born in 1951 in Tehran, where he received his 
veterinary training. He began his professional career in 1978 in 
Elam Province of the Islamic Republic of Iran, first as a provincial 
field veterinary officer and then as an Officer for Quarantine Affairs 
responsible mainly for controlling animals and animal products 
for export and compliance with World Organisation for Animal 
Health (OIE) requirements. He received training in microbiology 
and quality control at the Meat Research Institute of New Zealand, 
and throughout most of the 1990s Dr Kiani worked for the national 
veterinary service of the Islamic Republic of Iran, developing a 
robust veterinary service and being responsible for animal disease 
prevention and control. It was here that he became involved with 
professionals from the Food and Agriculture Organization of the 
United Nations working on the establishment of a national animal 
disease surveillance system to support the national rinderpest 
control plan. By the end of the second five-year national plan 
for rinderpest control and eradication (1998–2003), the Islamic 
Republic of Iran had received official recognition as rinderpest-free. 
In the intervening period, Dr Kiani also contributed significantly to 
rinderpest control programmes in Afghanistan, including training 
veterinary field units, conducting field and village investigations, 
and carrying out vaccination and surveillance activities and FAO 
follow-up projects (in 1996 and 1997) in the aftermath of rinderpest 
outbreaks in eastern parts of Afghanistan linked to the illegal 
movement of infected cattle from Pakistan. From 1998 to 2002, 
Dr Kiani served as Director of the Central Veterinary Laboratory 
for Diagnosis and Veterinary Drugs, Vaccine and Biological Quality 
Control under the Iran Veterinary Organization (IVO). 
Under the supervision of Dr Mark Rweyemamu, and later Dr Juan 
Lubroth, Head of the Emergency Prevention System (EMPRES) at 
FAO, Dr Kiani coordinated the work of the Regional Animal Disease 
Surveillance and Control Network (RADISCON), which was a 
precursor of the Global Framework for the Progressive Control 
of Transboundary Animal Diseases (GF-TADs) in scope, strategy 
and regional approach and covered 21 countries in the Near East 
and North Africa, including the Islamic Republic of Iran. He led this 
initiative aimed at establishing veterinary epidemiology units in the 
central veterinary services of beneficiary countries and improving 
disease information systems and disease reporting – both national 
and to OIE – through capacity building in disease surveillance 
and control activities for transboundary animal diseases such 
as rinderpest, foot-and-mouth disease (FMD), peste des petits 
ruminants (PPR), sheep pox and brucellosis. When RADISCON 
ended, Dr Kiani returned to IVO as Director of Animal Disease 
Surveillance, Prevention and Control, a position he held until the 
outbreaks of H5N1 highly pathogenic avian influenza (HPAI), when 
he was commissioned by FAO to serve as Regional Animal Health 
Adviser and technical manager for Central Asia. 
At the Global Declaration of Rinderpest Freedom, in Rome 
in 2011, FAO recognized Dr Kiani with a medal for his work 
in Afghanistan, Kazakhstan, Kyrgyzstan, Pakistan, Tajikistan, 
Turkmenistan and Uzbekistan as well as the Islamic Republic of 
Iran, and his contributions to global solidarity. 
In November 2015, in Afghanistan, Dr Kiani concluded his 
professional career. He was in Kabul a month before his death 
working on FMD, PPR and HPAI management and control; one 
photo shows him a bit tired but very present and ready to hear 
from field veterinarians about their needs and challenges in 
completing their daily activities and preparing for the next stage. 
The chapter closes with Dr Kiani as a great professional – not only 
because of his experience and technical skills, but also because 
of his capacity to listen with humility, always showing great interest 
and participation in whatever his interlocutors had to tell him as a 
sensitive educator. 
Ciao Dr Kiani. Ciao Ali. We will miss you,  
and your flame will continue to burn and inspire. 
In memoriam: Ali Gholam Kiani 
(1951–2015)
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The Emergency Prevention System (EMPRES) is an FAO programme, founded in 1994, with the goal of 
enhancing world food security, fighting transboundary animal and plant pests and diseases and reducing 
the adverse impact of food safety threats. EMPRES-Animal Health is the component dealing with the 
prevention and control of transboundary animal diseases (TADs).
To subscribe or to ask for information about EMPRES-Animal Health send an e-mail to:
empres-animal-health@fao.org or a fax to (+39) 06 57053023
For more information visit us at http://www.fao.org/ag/empres.html
EMPRES-Animal Health can assist countries in the shipment of samples for TAD diagnostic testing at 
a FAO reference laboratory and reference centre. Please contact Empres-Shipping-Service@fao.
org for information prior to sampling or shipment. Please note that sending samples out of a country 
requires an export permit from the Chief Veterinarian’s Office of the country and an import permit from 
the receiving country.
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